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The ever-increasing population and resource demand are putting a stress upon the planet’s 
resources. This increased demand places an even greater need today for the exploration 
of alternative, greener fuels that can aid in the alleviation of the traditionally used fossil fuels. 
One such method is in the production of acetone, butanol and ethanol (ABE) by the bacteria 
genus Clostridium spp. These gram-positive anaerobic bacteria were first characterised in 
the late 19th centaury and have been used throughout the 20th and 21st centauries for their 
solvent producing capability, most notably in the supply of weapons grade acetone during 
the first world war. After falling out of favour in the last half of the 20th century due to 
competition with cheaper and more readily available petrochemicals; interest in ABE 
production via Clostridium spp. has been on the rise in recent years as the ABE 
fermentation is investigated for its potential as a greener more renewable source of fuel 
production.  As interest in ABE fermentation has been on the rise in recent years, so too 
has our understanding of the genus as a whole. Traditionally C. Acetobutylicum first 
described by Chaim Weizmann in the early 20th centaury has been the industrial strain of 
choice. However, as the overall understanding of the strains has improved other strains 
have been explored for their industrial relevance. These are largely split into two 
characterisations, autotrophs who are able to fix CO2 and CO, converting them acetyl-CoA 
for solvent production and heterotrophs who are able to metabolise hexose sugars in 
solvent production. The strain used in this study is Clostridium saccharoperbutylacetonicum 
N1-4(HMT). Clostridium saccharoperbutylacetonicum N1-4(HMT) is a heterotrophic 
Clostridium species first described by (Hongo and Ogata, 1969) . 
 
Herein we have utilised CLEAVEÔ, this is a CRISPR/Cas system developed by Green 
biologics ltd. CLEAVEÔ was used for the deletion of the gene gapN from the genome of 
Clostridium saccharoperbutylacetonicum N1-4(HMT). GapN is a cytosolic non-
phosphorylating NADP-dependant GAPDH that catalyses the irreversible oxidation of 
glyceraldehye-3-phospate (G3P) to 3-phospholycerate. Deletion of gapN causes a 
reduction in acid production, an increased rate of solvent production to pre-toxic 
concentrations, as well as an increase in ATP and ratio of NADH:NAD+. Additionally, the 
deletion of gapN results in an increase in formic and lactic acid production that is believed 
to be as a result of pyruvate accumulation in response to the earlier shift into 
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The work in this thesis focuses on improving processes of renewable n-butanol and acetone 
production from the solvent-producing bacterium C. saccharoperbutylacetonicum N1-4 
(HMT). In addition to the establishment of fermentation and growth techniques, new 
molecular biology methodology has been explored to further understand the metabolism C. 
saccharoperbutylacetonicum N1-4(HMT) and improve the capacity for solvent production. 
This chapter will first provide the background knowledge on the current state of fossil fuel 
utilisation and renewable energy alternatives. The focus will then shift to introducing the 
unique metabolism of solventogenic Clostridia strains, and provide an in-depth analysis of 
the available tools for genetic manipulation across Clostridia. Finally examples of how these 
tools have been used in each strain alongside introducing alternative hosts for ABE 
production 
 
1.2 Fossil Fuels  
 
1.2.1 Global supply and demand for fossil fuels 
 
Currently, the global appetite for energy is ever increasing as more and more countries 
become wealthier and more industrialised. This insatiable appetite for energy is being met 
mainly by traditional fossil fuels, coal, gas and oil. Currently 91.6% of power generation 
globally is met by fossil fuels, with the remaining 8.4% being met by renewables (British 
Petroleum, 2018). Overall the global energy demand for the year 2017 rose by 2.2%, 
substantially higher than the average per year from the last 10 years of 1.7%. This sharp 
growth has been mainly due to global increases in GDP driven by the expanding markets 
in China and India accounting for 40% of the overall observed increase (British Petroleum, 
2018).  
 
Up to this point there has been little change in the mixture of sources used for power 
generation compared to that in 1998. This is large part due to the decrease in nuclear power, 
alongside the massive economic growth China has seen in the past 20 years. The 
knowledge that little has changed on a global scale in terms of energy production is 
daunting, especially as renewables have seen the largest growth rates in recent years (16.2 
% between 2006 – 2016) over traditional fossil fuels. Renewables however, still only 
account for 8.4% of power generation globally. In addition to this, 2017 saw CO2 rise by 
1.6% (British Petroleum, 2018; “Global Energy & CO 2 Status Report,” 2018), the first time 




Currently the best models predict that if the world continues to use fuel at a rate similar to 
that of 2006 then oil, coal and gas will be diminished in around 40,200 and 70 years 
respectively (Shafiee and Topal, 2009). However as has been shown in years from 2006-
2016, overall consumption of oil, coal and particularly natural gas has been on the rise by 
1.1%, 1.3% and 2.3% respectively. This paints a dreary picture for energy consumption 
globally as the demand is increasing year on year.  
 
The increase in demand for fossil fuels in particular oil as it is the main source of energy for 
global transport, raises the additional question of energy security. Currently, the majority of 
the oil produced globally comes from regions of political, social and economic uncertainty, 
such as Iraq, Venezuela and Nigeria (Bang, 2010; Lilliestam, 2012). It is because of the 
ever-increasing demand on fossil fuels that regions such as the USA and Europe have 
become dependent on these unstable regions for their energy demands. However, because 
of these factors of instability, the USA and Europe have recognised that their dependency 
on imported energy must be reduced, and they have identified a need to explore alternative 




Biofuels are energy carriers whose energy has been stored by means of carbon fixation in 
biological material over a relatively short period, i.e. decades as opposed to millennia such 
as in the form of petroleum-based fossil fuels. Biofuel production is diverse ranging from 
gasses such as hydrogen and methane, liquids in the form of ethanol, butanol, fatty acid 
methyl esters (FAMES) and to solids such as wood. In recent years a number of regulatory 
requirements in the face of depletion of fossil fuels has created a market place for biofuels 
as a commodity. The EU adopted legislation in 2009 stating that 10% of all transport fuel 
should be renewable by the year 2020 (EASAC, 2012). In addition, the USA in 2007 passed 
legislation that would require an aggregate of 36 billion gallons of ethanol (or equivalents) 
from renewables to be used in transport by 2020 (United States Congress, 2007).   
 
1.3.1 First generation biofuels 
 
First generation biofuels are those that are derived from biomass that could be more often 
than not considered edible, such as crop plants in the form of starch from corn and wheat, 
sucrose from sugar cane / sugar beets and oils in the form of palm oil and canola oil. 
Currently, bioethanol and bio-diesel are the two main first generation biofuels produced 
using these feedstocks. The production of bio ethanol largely relies upon the fermentation 
of starch and sugar biomass. The USA leads global production of bio ethanol at 33.7 x 109 
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L / year produced, followed by Brazil at 24.3 x 109 L / year produced (Lee and Lavoie, 
2013)(Aro, 2016). Unlike bioethanol production which typically involves fermentation 
straight from a sucrose source or following a simple hydrolysis of starch material such as 
corn or wheat, biodiesel production is considered a chemical process. The production of 
biodiesel requires filtering and transesterification of fatty acids to allow it to be used. 
Germany is the largest producer of biodiesel at 9.2 x 109 L / year (Sorda et al., 2010)  
 
Despite good intentions, first generation biofuels are largely now banned, in the EU due to 
the fact that they not only compete with land for food production, in the EASAC 2012 study 
revealed that once the processing of first generations biofuels was taken into consideration 
from the biomass cultivation, to fuel production they provide no or little benefit to the 
greenhouse gas effect and have a detrimental effect on food agriculture as well as natural 
ecosystems (EASAC, 2012). In addition to this, the fluctuation and cost associated with first 
generation biofuel feedstocks can often result in abandonment of biofuel production. This 
was seen in Brazil in 2012, were the production of around 1 L of bioethanol from sugar cane 
was around $ 0.30/0.35 / L whereas the price of raw sugar cane was around $ 0.20 / lb and 
due to these low margins, the market favoured the production of the raw sugar instead of 
bioethanol (Sorda et al., 2010).  
 
1.3.2 Second generation and third generation biofuels 
 
Second generation biofuels are produced using biomass that is considered not suitable for 
consumption. Most commonly this takes the form of waste lignocellulosic biomass from 
wheat stover, corn stover and rice stover (i.e. the plant material left over from harvest). The 
use of waste lignocellulose helps create synergy in the agricultural cycle, enabling the 
productive use of an otherwise wasted by product. In addition to waste lignocellulose 
second generation biofuels are also produced from plants that have been specifically grown 
as bioenergy crops. Bioenergy crops such as perennial grasses, Miscanthus giganteus 
(Boehmel et al., 2008) and Panicum virgatum (switchgrass) (David and Ragauskas, 2010) 
are grown in marginal lands that are not able to sustain agricultural crops but can be used 
in the production of second-generation biofuels. The unfortunate drawback of second-
generation biofuels is that they require extensive pre-treatment from mechanical, chemical 
or enzymatic methods (Braguglia et al., 2017; Hijosa-Valsero et al., 2017). Third generation 
biofuels are often described as those produced from algal biomass, although these are 




1.3.3 Biofuel applications for n-butanol  
 
Currently, bioethanol is the largest produced biofuel globally. This, however is down to its 
ease of production rather than its ability as a biofuel. Butanol is a far superior biofuel in 
comparison to ethanol and a number of other fuel types, and a breakdown of the properties 
of butanol in comparison to a number of other fuel types can be seen in Table 1.1. The 
advantages of Butanol over bioethanol include: (i) Higher energy density over ethanol (25 
%), allowing for increased range in Km/ h per mass of fuel. (ii) lower volatility due to the 
increased length of carbon chain. This is advantageous as gasoline / butanol fuel blends 
will have less of a tendency towards cavitation or vapour lock problems; (iii) Heat 
vaporisation, and autoignition of butanol is lower than both ethanol and methanol; (iv) 
increased viscosity of butanol results in decreased wear for rubber tubing, pumps and 
general infrastructure, this will increase longevity of infrastructure and reduce frequency of 
maintenance of perishables; (v) Lower water solubility; meaning reduced hygroscopicity 
and better miscibility with fuel, meaning that cars would not require modifications even with 
a 10% butanol gasoline blend (Bharathiraja et al., 2017; Dürre, 2008; Green, 2011; Lee et 
al., 2008). It has also been demonstrated that butanol can be used on its own as a pure 
motor fuel. This was accomplished by David Ramey (Autoblogcom. 2019) in the USA in 
2005 and 2007 when he travelled across America fuelled only by butanol in a car with no 
modifications. This has also been demonstrated in the form of biobutanol by Celtic 
renewables (Bbccouk. 2019. BBC News) demonstrating the ability of butanol as a drop-in 
fuel replacement to gasoline.  
 
Butanol is not only useful in fuel blends or as a drop-in replacement for conventional 
gasoline, it is also used in a number of industrial applications. Butanol is used for the 
production of butyl acrylic, which is subsequently used in the manufacturing of polymer 
coatings, adhesives, plastics, resins and as an additive in the leather and paper industry. 
Additional products produced from butanol are butyl glycol in industrial solvents, butyl 
acetate used in prints and as a flavouring agent in the food and drink industry (Dürre, 2008). 
As of 2008 the global market for n-butanol was around 2.8 million tons at a valuation of 
roughly $ 5 billion USD, with projected valuation of $ 247 billion dollars by 2020, due to the 
advantageous properties of butanol over ethanol and biodiesel (Bharathiraja et al., 2017). 
As long as the process economics are kept competitive with those of petrochemical-derived 
butanol, the production of biobased n-butanol will continue to be an economically viable 




1.4 History of biobutanol production 
 
The industrial application of solvent-producing Clostridium was first exploited at the turn of 
the 20th century. Strange and Graham Ltd. were the first manufacturer to incorporate 
fermentative alcohol in the production of their synthetic rubbers in 1910. During this period 
the company hired a Jewish Russian Chemist Chiam Weizmann, who had arrived in 
Manchester from Berlin in 1904. At Manchester Chiam Weizmann assisted on the 
investigation into the production of butadiene and isoprene via microbial fermentative. Not 
a microbiologist by trade Weizmann set about becoming one between the years of 1912 
and 1914. Following his termination of contract with Strange and Graham in 1912 he 
continued his investigation into fermentative microbiology for the production of synthetic 
rubber, concluding that production of butanol by fermentative microbiology was key for the 
success of synthetic rubber production. From 1912 to 1914 period, Weizmann isolated a 
number of bacterial strains, one of which he had called “BY” that later became known as 
Clostridium acetobutylicum and further known as the Weizmann strain, this strain was able 
to metabolise a number of starch substrates as well as produce higher concentrations of 
acetone and butanol than the original Fernbach strain (Bengelsdorf and Dürre, 2017; Gi 
Moon et al., 2015; Jones and Woods, 1986). 
 
The outbreak of the first world war shifted Weizmann’s focus away from rubber production 
to the production of acetone as a component of nitro cellulose, to form cordite. Cordite is a 
smokeless gunpowder that was used in naval munitions during the first world war. Having 
spent time developing his fermentation methodology for the production of acetone via 
Table 1.1 Properties and applications of n-butanol  
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microbial fermentation, he was awarded a patent for this method in March of 1915. The 
following year Weizmann was summoned by Winston Churchill, who at the time was acting 
Lord of the Admiralty, who tasked Weizmann with undertaking the pilot plant production of 
acetone for cordite. These pilot plants were so successful that the Royal Naval Cordite 
factory was established in Dorset, where 6 distilleries were adapted for the production of 
acetone for cordite using the patented Weizmann methodology.  
 
Commercial production of acetone and butanol continued globally using licenced version of 
the Weizmann patent until the late 1950’s / early 1960’s. Unfortunately, production was 
unable to keep up with unprecedented growth of the petrochemical industry. Due to the this 
alongside the increase in the cost of substrates (starch and molasses) production had all 
bit stopped in most of Europe and the USA during the 1960’s (Jones and Woods, 1986). 
However, increased oil prices and the global drive for discovery of green energy countries 
such as China (Jiang et al., 2015) and Brazil (Green, 2011) have been quick to re-adopt 
ABE fermentation. More recently companies such as Green Biologics (Lane and Digest, 
2014) and Celtic Renewables (2019. BBC News) have initiated industrial solvent production 
via ABE fermentation in the USA and Scotland, respectively. An overview of key milestones 



































1.5 ABE Fermentation 
 
1.5.1 Solventogenic clostridial species 
 
Clostridia are a class of Gram-positive, anaerobic, rod shaped endospore forming bacteria 
with a low GC content. Clostridia play key roles in both human health and disease with 
Clostridium perfringens, C. difficile, C. tetani and C. botulinum known opportunistic 
pathogenic bacteria (Kenneth Todar, n.d.). However, solventogenic clostridia have a safe 
history of use in the production of acetone and butanol. The best known and most studied 
of the industrial solventogenic clostridial species is C. acetobutylicum (Aristilde et al., 2015; 
Cho et al., 2012; Clare M. Cooksley et al., 2012; Heap et al., 2007; Jones and Keis, 1995; 
Kaminski et al., 2011; Poehlein et al., 2017; Ryan S. Senger, 2009) also known as the 
Weizmann strain; it is second only to yeast in terms of global ethanol production (Bao et al., 
2011) and since its original discovery has been used as a model organism for endospore 
formation (Nölling et al., 2001). In the century that has passed since the discovery of the 
original Weizmann strain, strains such as Clostridium beijerinckii (Jones and Keis, 1995) 
and Clostridium saccharoperbutylacetonicum (Hongo and Ogata, 1969) have surpassed 
the original Weizmann strain as the preferred choice for ABE fermentation when grown on 
carbohydrate material. Acetogens such as Clostridium ljungdahlii (Köpke et al., 2010) and 
Clostridium autoethanogenum (Marcellin et al., 2016; Minton et al., 2016) have shown that 
these versatile bugs are able to fix simple C1 carbons for the production of biofuels (Jiang 
et al., 2015; Köpke et al., 2010; Marcellin et al., 2016).   
 
1.5.2 Feedstock Metabolism 
 
Clostridia are able to utilize a large variety of carbohydrate sources, from simple mono- and 
disaccharides, through to complex polysaccharides such as cellulose and hemicellulose, 
making them ideal candidates to metabolise a large variety of waste material (Al-Shorgani 
et al., 2012b; Lynd et al., 2002; Shaheen et al., 2000; Takors et al., 2018). A recent genomic 
study found that throughout commonly used industrial strains such as C. beijerinckii, C. 
saccharobutylicum, C. acetobutylicum and C. saccharoperbutylacetonicum genes for 
sucrose-specific phosphotransferase systems and sucrose degradation were present, as 
well as for starch degradation (Poehlein et al., 2017). In addition to heterotrophic growth, 
some clostridia can also grow autotrophically by fixing CO2 and CO chemolithotrophically 
(Drake et al., 2008) converting them to acetyl-CoA for solvent production.  
 
Industrial feedstocks such as brewers’ grain can often contain a mixture of C5 and C6 
sugars including glucose, xylose, arabinose and mannose (Tracy et al., 2012). This C5/C6 
mixture has a high propensity to cause carbon catabolite repression (CCR), whereby 
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utilisation of one sugar (usually a C6 sugar) will predominate and metabolism of any other 
sugars present in the media will not take place (Bruder et al., 2015). CCR is a problem for 
ABE fermentation as the C5 sugar xylose is an abundant component in lignocellulosic 
feedstocks, and in the presence of glucose this xylose is not metabolised until glucose and 
other C6 sugars have been used up (Ren et al., 2010).  
 
Autotrophic and heterotrophic growth both lead to the production of acetyl-CoA. In the case 
of autotrophic metabolism, the production of acetyl-CoA involves the use of the Wood–
Ljungdahl pathway in which two moles of CO2 are reduced to one mole of acetyl-CoA using 
H2 and CO to produce reducing equivalents. The Wood–Ljungdahl pathway itself is split into 
two parts, an Eastern and a Western branch. In the Eastern branch formate dehydrogenase 
(FDH) is used to reduce CO2 to formate, and formate is then attached to a tetrahydrofolate 
and further reduced to a methyl-group. In the Western branch one molecule of CO2 is 
reduced directly to CO by part of the bifunctional CO Dehydrogenase/Acetyl-CoA Synthase 
complex (CODH/ACS). Carbonyl- and methyl- groups from both branches are combined in 
the Acetyl-CoA Synthase complex with a molecule of coenzyme-A to form acetyl-CoA 
(Ragsdale, 2008) (Figure 1.2) 
 
During heterotrophic growth, hexose and cellulose sugars are metabolised through 
glycolysis, resulting in 2 moles of pyruvate per 1 mole of hexose with a net production of 2 
moles of ATP and 2 moles of NADH, or in the production of NADPH at a loss of 1 ATP at 
the conversion stage of Glyceraldehyde 3-phosphate to 3 – Phosphoglyceric acid (Ren et 
al., 2016). Pentose sugars flow into glycolysis via the Pentose Phosphate Pathway (PPP) 
or via the Phosphoketalse pathway (PKP). Recently it has been shown that in a hexose 
pentose mixture, flux from the PPP into glycolysis is minimal with a large accumulation of 
PPP intermediates (Aristilde et al., 2015). The pyruvate resulting from the process of 
glycolysis is cleaved by pyruvate ferredoxin oxidoreductase in the presence of coenzyme A 
to produce acetyl-CoA and reduced ferredoxin. (Figure 1.2).  
 
Now that an overview of feedstock metabolism has been given, the following sections will 
focus on the unique growth physiology of solventogenic Clostridia. This growth physiology 
is unique in that can often be broken up into two distinct phases, acidogenesis, in which 
there is the production of acetic and butyric acid; and solventogenesis in which the acids 
















Figure 1.2 Overview of metabolism of autotrophs and heterotrophs leading to Acetyl -
CoA in Clostridia. Glycolysis is shown in blue, the pentose phosphate and phosophketolase 
pathway are shown in pink. The Wood–Ljungdahl pathway is shown in yellow. Enzyme 
abbreviations are as follows; FDH, formate dehydrogenase; FTS, formyl-THF synthase; 
MTC, methenyl-THF cyclohydrolase; MTD, methylene-THF dehydrogenase; MTR, methyl 
transferase; MTRS, methylene-THF reductase; PFK-1, ACS/ CODH, acetyl-CoA 
synthase/CO dehydrogenase; GPI, phosphoglucose isomerase; PFK-1, 
phosphofructokinase;ALDO, fructose biphosphate aldolase; GAPDH, glyceraldehyde 
phosphate dehydrogenase; GapN, glyceraldehyde -3 phosphate dehydrogenase; PGM, 
phosphoglycerate mutase; ENO, enolase; PK, pyruvate kinase; PFOR, pyruvate:ferredoxin 
oxidoreductase; PGK, phosphoglycerate kinase.  
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1.5.3 Acidogenesis 
During acidogenesis, sugars consumed during growth are typically metabolised to form 
acetic acid and butyric acid, H2 and CO2. The production of acetic acid and butyric acid 
involves the enzymes phosphate acetyltransferase (Pta), acetate kinase (Ack), 
butyryltransferase (Ptb), and butyrate kinase (Buk1) (Figure 1.2). In both pathways of 
acidogensis, additional ATP is generated in the final phosphorylation reaction. Acidogensis 
typically occurs during the log phase of growth when the cells are at their most vegetative 
in conditions were the pH is typically greater than 5 and there is a depletion of iron. The 
significant production of the acids leads to acid accumulation externally in the media and a 
significant drop in the surrounding pH. If left unchecked, the undissociated acids would 
diffuse back into the cell, destroying the proton gradient and inhibiting cell growth. To 
Overcome this, the cells trigger what is commonly known as “solventogenic switch” whereby 
the genes involved in solvent production become expressed, producing the traditionally 
seen ABE solvents to overcome rising acid concentrations (Jones and Woods, 1986; Lee 
et al., 2008).  
 
If unchecked by the solventogenesis switch acid accumulation in concentrations of between 
57-60 mmol L -1 can result in acid crash, whereby the cells will fail to shift into 
solventogenesis. This results in decreased solvent production and cessation of glucose 
uptake. In addition to this, at acid concentrations of between 240-350 mmol L -1 
solventogenesis can be inhibited completely, resulting in cell death (Chen and Blaschek, 
1999; Maddox et al., 2000). Acid crash is typically seen in unregulated batch fermentations 









Figure 1.3 ABE Fermentation pathway A). The major products during acidogenesis are shown in the blue boxes, 
while those mainly produced during solventogenesis are shown in the green boxes. The dashes lines show the CoA-
T pathway, where organic acids are re-assimilated during solventogenic growth. Enzymes are shown in italics. 
Asterisk (*) indicates genes and enzymes encoded by the sol operon. Pathway in red arrow indicates isopropanol 
production naturally occurs C. beijerinckii; Pathway in grey arrow indicates lactate production under un- favourable 
condition B). Butanol formation routes via “hot and cold channel(s)” in Clostridium. Blue arrows indicate the cold 
channel, which is the organic acid assimilation route. Red arrows indicate the hot channel, which is the direct route. 





The shift from acidogensis into solventogenesis is closely linked to that of sporulation, as 
solvent production allows the cells to survive in a metabolically active form for a longer 
period of time under acid stress. Solventogenesis doe come at a cost as the solvents 
produced (mainly butanol) are by in large toxic to the cells. The initiation of solventogenesis 
initiates the process of long-term survival through the formation of endospores. The master 
regulator for the solventogenic shift is the transcription factor Spo0A (Ravagnani et al., 
2000). Spo0A is activated when it is phosphorylated by the phosphorelay two-component 
signal transduction system (Sandoval et al., 2015) in response to the drop in pH and 
accumulation of ATP, H2 and CO2 during acidogensis. Upon phosphorylation Spo0A acts 
as the master regulator of both solventogenesis as well as sporulation, and deletion of 
Spo0A in Clostridium saccharoperbutylacetonicum N1-4(HMT) resulted in abolished 
solvent production on top of a detrimental effect on vegetative cells (Atmadjaja et al., 2019). 
Expression of Spo0A is a balancing act, and previous work shows that Spo0A 
overexpression favours a shift towards sporulation over solvent production (Harris et al., 
2002). 
 
Regulation for the shift from acidogensis to solventogenesis is not only dependent upon the 
drop in pH due to acid production, the reducing environment created in the production of 
acetyl-CoA also play a key role. Electron flow within Clostridium is governed by ferredoxin. 
The cleavage of pyruvate to acetyl-CoA results in the transfer of an electron from a reduced 
ferredoxin to the hydrogenase, which uses the proton as its final electron acceptor and 
results in a rapid drop in the redox potential due to the increased H2 produced at this step. 
Additionally, fermentation of carbohydrates increases the NAD(P)H:NAD(P)+ ratio within the 
cell, this ratio shift has been shown to result in the dissociation of the Rex complex from 
genes involved in butanol production aiding in the shift into solventogenesis (McLaughlin et 
al., 2010; Wietzke and Bahl, 2012). Overall the shift from acidogensis to solventogenesis is 
regulated a complex network of phosphorylation, redox and pH drop due to acid production.  
 
Upon shifting into solventogenesis, expression of genes involved in the solvent production 
takes place. The operon responsible for this is the sol operon. and the placement and 
arrangement of the sol operon can vary depending upon the Clostridium species. The Type 
I operon found in strains such as C. acetobutylicum is comprised of an adhE–ctfA–ctfB 
cluster (encoding a bifunctional butyraldehyde/butanol dehydrogenase and the two subunits 
of CoA transferase), and an adjacent, convergently transcribed, monocistronic adc operon 
(encoding acetoacetate decarboxylase). The Type II operon consisting of ald–ctfA–ctfB–
adc (encoding NADH-dependent aldehyde dehydrogenase, CoA transferase, and 
acetoacetate decarboxylase) found in the genome in strains such as C. 
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saccharoperbutylacetonicum N1-4(HMT) and C. beijerinckii (Poehlein et al., 














There are two pathways for butanol production, these are known as the “hot” and “cold” 
channels. The “cold channel” generates butanol via the re-assimilation of acetate and 
butyrate into acetyl-CoA and butyryl-CoA via the CoA- transferase (CoA-T) pathway. From 
here, acetyl-CoA is either converted to butyryl-CoA or reduced to ethanol. If converted to 
butyryl-CoA, butyryl-CoA will be reduced to form butanol. In the “Hot Channel” organic acid 
assimilation is prevented and is responsible for the direct conversion of acetyl-CoA to 
butyryl-CoA followed by reduction to butanol (Jang et al., 2012). The hot channel for butanol 
production prevents yield losses to CO2 and acetone, as 1 mole of acetoacetate is 
generated from each mol of assimilated organic acid. acetoacetate is then decarboxylated 
into CO2 and acetone (Jang et al., 2012; Ou et al., 2015). In their study Jang et. Al., (2012) 
show that a reduction in the “cold channel” does indeed lead to a reduction in organic acid 
production however it also results in reduced butanol yields, hence decreasing the “cold 
channel” does not increase butanol yield unless organic acid production is stopped at the 
same time (Jang et al., 2012) (Figure 1.3).  
 
  
Figure 1.4 Type I and Type II Sol operon. A). Type I operon found in C. acetobutylicum. The sol 
operon structure of C. acetobutylicum is different from beijerinckii, and C. 
saccharoperbutylacetonicum, where the aad replaces aldH, and adc is part of a separate operon; 
B). Type II  C. beijerinckii, and C. saccharoperbutylacetonicum. The sol operon structure of C. bei- 
jerinckii, and C. saccharoperbutylacetonicum are the same (Ying., 2018) 
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1.6 Limitation of ABE fermentation and possible strategies for 
improvement of ABE fermentation 
 
The industrial interest in the ABE fermentation process has continued to grow in recent 
years as butanol’s potential as a chemical or fuel is ever-increasing. Companies such as 
Green Biologics Ltd who specialise in traditional lignocellulose ABE fermentation, and 
Lanzatech who specialise in C1 waste utilisation using acetogens and autotrophs have 
been paving the way for the industrial usage of Clostridium. As desirable as the idea of 
butanol production from ABE fermentation may be, the process itself needs to be 
economically viable. To achieve this economic viability improvements to current systems 
must be made. These improvements include (i) Acquisition of cheap readily available 
substrate that does not compete with land or human survivability; (ii) improvements of 
overall solvent yields and improvements to solvent recovery; (iii) improvements in strain 
capability to withstand toxicity of solvents, produce higher concentrations of solvents and 
diversification of compounds created using butanol as a precursor.  
 
The cost of substrate in a conventional ABE corn starch process accounts for up to 79% of 
the total cost of production (Green, 2011). Due to this cost, it is imperative that cheap 
alternative feedstocks are sourced. As suggested previously in Section 1.3.2, lignocellulosic 
material has excellent potential as a feedstock. Lignocellulose is the most abundant 
renewable resource on earth, with India alone producing in excess of 370 million tonnes of 
this biomass every year from plant, rice husk and saw from saw mills (Kumar and Gayen, 
2011). Due to the saccharolytic ability of Clostridium, lignocellulose has the potential to be 
an ideal substrate for ABE fermentation. However, to be efficiently metabolised during 
fermentation the lignocellulose must first be pre-treated. Pre-treatment enables (1) 
breakdown of lignin shell of lignocellulosic material; (2) breakdown of a large proportion of 
crystalline cellulose, this is key as it aids the Clostridium cellulosomes to further metabolise 
cellulose (Ezeji et al., 2007; Mitchell et al., 1995); (3) Increasing porousness, enabling 
access for enzymes. Pre-treatment methodologies have been reviewed extensively by 
Bharathiraja et al., (2017) who revealed that most methodologies for lignocellulose pre-
treatment are highley efficient and can recover approximately 90 % of the fermentable sugar 
material. As discussed in Section 1.4.2 certain strains of solventogenic Clostridium are able 
to metabolise simple C1 carbons for the production of ethanol and acetate primarily (Köpke 
et al., 2010; Marcellin et al., 2016). In addition to lignocellulose the C1 waste gases from 
power plants and steel mills, syngas from agricultural waste, or reformed methane from bio 





One of the key issues that faces the industrialisation of the ABE fermentation process is the 
overall low yields of butanol that are obtainable. Typically, in fermentation broths there is a 
low percentage of butanol present usually around 1-2 % (<20 g L -1). This low yield is largely 
due to the toxic effect of butanol on the cells. Low butanol yields of < 0.36 g / g of sugar 
may be due to the heterofermentation of sugars and low butanol productivity due to low cell 
counts, which will also increase the cost of product recovery (Green, 2011; Ni and Sun, 
2009; Tashiro et al., 2013). Fermentation conditions and optimisation have been extensively 
studied for various strains (Braguglia et al., 2017; Ezeji et al., 2003; Green, 2011; Latif et 
al., 2014; Liao et al., 2017; Procentese et al., 2018; Wang et al., 2012; Zhang et al., 2018) 
and batch fermentation is widely adopted for industrial ABE fermentation due to ease of 
use. Fed batch and continual fermentation are other alternative fermentation techniques 
used, although extended production times come with the trade-off of having lower 
concentrations of solvents per litre compared to batch processes. For successful fed batch 
or continuous fermentation, solvent recovery must take place throughout not only in a bid 
to maximise overall yield but also to maintain butanol concentrations that are below toxic 
levels. A number of recovery methods have been trialled over the years including 
pervaporation, gas stripping, liquid–liquid extraction, and liquid-membrane extraction 
(Bharathiraja et al., 2017). Fed batch cultures using pervaporation have been shown to 
produce butanol concentrations of 105 gL-1, whereas traditional batch fermentation 
achieved butanol concentrations of around 12.8 gL-1 (Qureshi and Blaschek, 2000).  
 
Finally, a major inefficiency within in the ABE process is the bacteria themselves. The 
butanol that they produce is inherently toxic, and because of this butanol concentrations 
rarely exceed 1- 2 % (v/v) in the fermentation media. Butanol has membrane distorting 
properties, where the hydrophobic chain and polar group can elicit severe damage to the 
cell (Baer et al., 1987)(Bowles, 1985). Butanol toxicity affects the cells in a number of ways; 
(i) ion transport is disrupted; (ii) nutrient transportation; (iii) composition of the phospholipid 
membrane is destroyed; (iv) finally the cells metabolism breaks down (Ezeji et al., 2010). 
Several attempts at elevating butanol toxicity have been attempted with limited success 
(Dunlop et al., 2011; Liu et al., 2014). In addition to this, phage infections have occurred 
previously in an industrial setting, in the 1980’s in South Africa, a phage infection resulted 
in loss of ABE production. This resulted in strain rotation and isolation to strains resistant to 
the infection to be able to restart production (Jones et al., 2000).  
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1.7 Metabolic engineering in Clostridium 
 
Despite the significant understanding of the Clostridium genus and its genome, the genus 
is notoriously difficult to engineer. As a result, tools available for genetic engineering of 
Clostridium have lagged behind those for Gram-negative species such as E. coli. Moreover, 
development of tools for creation of robust strain development in C. 
saccharoperbutylacetonicum N1-4(HMT) has lagged behind that of other Clostridium 
strains such as C. acetobutylicum and C. beijerinckii. Herein, we investigate the current 
technologies used for genetic engineering and how these tools have been applied in the 





The ClosTron system was developed by Heap et al., (2007) as a Clostridium specific system 
that takes advantage of the TargetTron system developed by Sigma Aldrich, with the initial 
ClosTron vector (pMTL007) a tailored version of the plasmid pACD4k-C. Bacterial group II 
intron technology allows for site directed mutagenesis by retrohoming of the Mobile group 
II introns. Mobile group type II introns are retroelements responsible for reverse encoding 
transcriptases (RT), inserting into specific DNA target sites at a high frequency. The process 
of retrohoming involves the self-splicing of group II introns that are then reverse transcribed 
by their own reverse transcriptases. The process of retrohoming is mediated by a 
ribonuclease (RNP) complex consisting of an RNA lariat and an intron encoded protein. 
The RNP inserts bound RNA into one strand of the double stranded genomic target site, 
the RNA is then reverse transcribed resulting in its removal and replacement of it by DNA 
by the host repair machinery. This results in a stable integrated intron (Zhong et al., 2003) 
(Figure 1.5).  
 
The ClosTron system was developed to include a set of standardized parts such as 
promoters, origins of replication and retrotransposition-activated selection markers (RAM) 
suitable in Clostridium. The ClosTron introns were designed in silico using software that 
identifies sequences based for a 35 bp region that is recognised by the intron-encoded 
protein, allowing for targeting of the intron into the desired gene (Heap et al., 2010). 
ClosTron has been used for a number of targeted gene disruptions within a number of 
Clostridium spp. (Antunes et al., 2011; Cartman et al., 2010; Clare M Cooksley et al., 2012; 




1.7.2 Double crossover recombination events 
 
Double crossover recombination events allow for targeted gene disruption. The first cross 
over event incorporates a vector containing a pair of homology arms flanking a cargo 
sequence into the target locus via homologous recombination (HR). The second crossover 
event deletes the specific region between the homologous sequence, replacing it with the 
cargo DNA Figure 1.5. Double crossover events rely on the use of counter selection 
markers, these being elements that when present result in cell death. Counter selection 
markers are useful for selecting chromosomal insertions that do not contain any undesirable 
parts, i.e. vector backbone from the incomplete cross over event. Counter selection markers 
specific to Clostridium spp. were first developed by (Awad et al., 1995; Bannam et al., 1995).  
 
One such system developed by Soucaille and colleagues (Soucaille et al., 2008) uses a 
negative selection marker for the second cross over event similar to that developed in B. 
subtilis (Fabret et al., 2002). In order to work correctly, this method requires a C. 
acetobutylicum strain that lacks the gene upp. The upp gene encodes the uracil 
phosphoribosyl-transferase and the upp deficient strain will be resistant to 5-fluorouracil. A 
knockout plasmid is required for this to work correctly. The knockout plasmid will contain 
DNA sequences that flank the region that is going to be deleted from the genome. An 
erythromycin cassette flanked on both sides by FRT sites is inserted into the plasmid that 
already contains a functional copy of the upp gene previously removed from the genome. 
Following transformation of the knockout plasmid, colonies were selected based upon their 
resistance to 5-fluorouracil and erythromycin. Introduction of a plasmid containing a Flp 
recombinase will allow for the removal of the erythromycin cassette and allow for additional 
genes to be cloned in as part of the process.  
 
Allelic coupled exchange (ACE) is another form of coupling a counter selection marker gene 
to a desired double crossover event Figure 1.5. ACE methodology has been demonstrated 
in two ways. The first method involves exploitation of resistance to 5-fluorouracil by 
disruption of the pyrE or pyrF gene. ACE does not rely on the cells being auxotrophic for 
uracil prior to recombination, it also does not require a heterologous version of the gene to 
be used as counter selection marker. The process of ACE involves the use of asymmetric 
homology arms that direct the order in which the recombination occurs. The longer of the 
two arms ~1200 bp is immediately downstream of the pyrE or pyrF and directs first 
crossover event that incorporates the entire plasmid into the genome. The second 
crossover event is led by the shorter of the arms ~ 300 bp, which is homologous to a 300 
bp internal region pyrE or pyrF and results in removal of the plasmid backbone. Following 
the second recombination event the wild type pyrE gene is replaced by a truncated form 
that will then allow for screening via 5-fluorouracil resistance (Heap et al., 2012). 
 34 
Alternatively, a promoter-less heterologous pyrE gene or antibiotic marker can be inserted 
in the integration vector with the regions of homology. This is done in such a way that a 
successful double crossover event would place the silent gene directly downstream of a 
constitutive promoter (Heap et al., 2012). The use of ACE technology allows for the 
circumvention of prerequisite mutant strains created using the pMTL ClosTron plasmids 
because of the use of antibiotic markers.  
 
  
Figure 1.5 Counter selection markers used in Clostridium spp. and their mechanisms of action. The gene 
of interest (G.O.I) is represented in red with the intended insert in blue and the counter selection marker in dark 
purple. Green and Blue bars represent regions of homology between the insert and the genome. A). ClosTron: 
RAM disrupted by a Group I intron (white triangle) is only active after the L1.LtrB intron is inserted into the 
chromosom; ; B). pyrE complementation: PyrE catalyzes conversion of 5-fluoroorotic acid (5FOA) to 5-
fluororotidine monophosphate (5FOMP) producing toxic fluorodeoxyuridine monophosphate (FdUTP); C). Allele-
Coupled Exchange: (1) double-crossover event at the pyrE locus results in truncated version of pyrE for counter 
selection with same mechanism as (B), (2) successful homologous recombination inserts a promoter-less copy of 
the pyrE gene directly downstream a native constitutive promoter, allowing production of uracil 5′ monophosphate 
(UMP). Note: must be performed on pyrE deficient strain; (D) Cas9: successful homologous recombination gRNA-






Clustered Regulatory Interspaced Palindromic Repeats (CRISPR) alongside their 
associated Cas proteins are part of the adaptive immune system found in bacteria. This 
CRISPR/Cas defence process is best described in three main stages; (i) adaption of new 
genetic material, results in spacer sequence acquisition and insertion into the CRISPR locus 
within the cell; (ii) once acquired, cas genes are expressed and the CRISPR locus is 
transcribed into long CRIPSR-RNA (pre-crRNA). The pre-crRNA is processed into mature 
crRNA by the Cas proteins and accessory factors; (iii) interfering DNA matching the crRNA 
and Cas proteins is destroyed (Boyaval et al., 2007).  
 
Sequence repeats and spacer length used in the CRISPR locus are typically conserved 
within organisms but can vary between species. Repeat regions in the CRIPSR cassette 
have been shown to be between 21-48 bp in length and spacers 26 -72 bp in length. Not 
all Cas proteins are found adjacent to the CRIPSR loci, and sometimes these CRIPSR loci 
rely upon trans-encoded factors. In addition to the spacer and repeat regions, there is a 
leader sequence that is conserved within the CRISPR locus relating to the direction of 
transcription of the crRNA (Rath et al., 2015). There is  high diversity within the Cas proteins, 
with Cas1 and Cas 2 involved in the adaption stage of the adaptive immune mechanism 
and are thought to be universal in CRISPR/Cas systems (Makarova et al., 2002). Outside 
of that, Cas proteins are typically broken down into three main groups, Type I, Type II and 
Type III (Figure 1.6). Type I systems are defined by the presence of the protein Cas3, which 
has both helicase and DNase domains responsible for the degradation of target DNA. There 
are 6 subtypes of Type I systems A through F all with varying Cas genes present. Outside 
of cas1, cas2 and cas3 Type I systems all encode a Cascade complex. This complex binds 
to crRNA and locate the target. Cascade complexes have been shown to enhance the 
acquisition stage (Sinkunas et al., 2011). Type II systems are responsible for encoding 
Cas1, Cas2 and the Cas9 protein. Like the cascade complex Cas9 assists in the adaption 
stage, takes part in crRNA processing and cleaves target DNA assisted by crRNA with an 
additional RNA (tracrRNA). Like Type I systems, Type II systems are divided into sub types,  
A and B (Chylinski et al., 2013; Martin Jinek et al., 2012). Finally Type III, contain the 
signature protein Cas10 who’s function is unclear at this point. Unlike Type I and Type II 
systems however, Type III systems have shown to target DNA as well as RNA (Staals et 




The first use of CRISPR/Cas systems for genetic modifications was by the Type II Cas9 
system known as spyCas9 (Martin Jinek et al., 2012). This system originated from 
Streptococcus pyogenes and was formed of a single Cas9 protein that is able to bind and 
implement a double stranded break to targeted DNA sequences. To be able to target 
sequences the spyCas9 system required a single guide RNA ~20 bp that was immediately 
adjacent to the protospacer adjacent to a motif (PAM). The PAM sight in this system was 
NGG and can be used to provide many possible target sites within a sequence.  
 
Within Clostridium genetic engineering by CRISPR/Cas has mostly been used as a counter-
selection method to screen against homologous recombination events Figure 1.5 (Bruder 
et al., 2016; Huang et al., 2016; Nagaraju et al., 2016; Wang et al., 2017a; Wasels et al., 
2017). One major drawback of CRISPR/Cas systems in Clostridium spp. is their lack of non-
homologous end-joining (NHEJ) systems meaning that Cas9-activated site directed 
breakage (DSB) can only be used to select against non-edited genes i.e. wild types (Xu et 
al., 2017). Despite recent advancements in genetic engineering tools and the advent of 
CRISPR/Cas toolkits within Clostridium spp., the influence of low plasmid transformation 
efficiencies, lack of recombineering, and lack of NHEJ tools and other characterized genetic 
parts still act as a barrier that needs to be overcome to take full advantage the Clostridium 











Figure 1.6 Model of crRNA processing and interference. A). In Type I systems, the pre-crRNA 
is processed by Cas5 or Cas6. DNA target interference requires Cas3 in addition to Cascade and 
crRNA. B). Type II systems use RNase III and tracrRNA for crRNA processing together with an 
unknown additional factor that perform 50 end trimming. Cas9 targets DNA in a crRNA-guided 
manner. C). The Type III systems also use Cas6 for crRNA processing, but in addition an 
unknown factor perform 30 end trimming. Here, the Type III Csm/Cmr complex is drawn as 
targeting DNA, but RNA may also be targeted 
 38 
 
1.8 Well-characterised examples of metabolic engineering in 
Clostridium spp. 
 
1.8.1 Engineered strains 
 
Throughout the short history of genetic manipulation of Clostridium spp., a major focus has 
been on increasing solvent production by targeting the genes that are involved in acid and 
solvent production. The first successful example of such metabolic engineering reported a 
recombinant C. acetobutylicum with up-regulated adc (encoding acetoacetate 
decarboxylase) and ctfAB (encoding CoA transferase) genes (Mermelstein et al., 1993). 
Batch fermentation of this recombinant strain resulted in the earlier expression of acetone-
forming enzymes leading to earlier acetone production. This recombinant strain produced 
elevated concentrations of acetone, butanol and ethanol of 95%, 37% and 90 % 
respectively. Another early study by Nair et al. (Nair and Papoutsakis, 1994) utilised the 
degenerated strain C. acetobutylicum M5 (Clark et al., 1989) that could no longer produce 
solvents or sporulate due to the loss of the pSOL1 mega plasmid encoding the alcohol 
dehydrogenase gene adhE. This strain could not be used for acetone production, but was 
able to produce butanol and ethanol. Despite its ability to produce butanol and ethanol, 
when butanol concentrations were around 10 g L -1 the adhE M5 strain shifted to ethanol 
production over butanol. The M5 strain of C. acetobutylicum has been used as a 
background strain in a number of studies as a platform for the introduction of solvent 
production minus acetone production as demonstrated by (Nair and Papoutsakis, 1994). 
However, recent studies by (Sillers et al., 2008) showed that the M5 strain lacks the 
metabolic flexibility to be able to change its redox poise effectively enough achieve a 
desirable electron balance. In the study, when Sillers et al. attempted to over express the 
adhE only strains with inactivated acetate kinases were able to produce transformants 
(Sillers et al., 2008), although these lead to increased acid production and decreased 
solvent production. This suggested that the strain was limited in its ability to balance redox 
potential and relied heavily on butyrate production as a means of balancing its production 
of reducing equivalents. Additional experiments have since been carried out to examine the 
effect of disruption of the butyrate forming pathway. In one study, the deletion of the buk1 
and pta genes encoding the butyrate kinase and phosphotransacetylase was carried out in 
an attempt to re-direct carbon flow through to solvent production and away from acid 
production (Green et al., 1996). The mutations were obtained by homologous, single cross-
over events. Overall, the pta knockout had decreased acetate production and increased 
butyrate production, with the opposite being true for the buk1 mutant. Solvent production 
was only affected in the buk1 mutant, in fact the buk1 deletion resulted in the strain being a 
butanol super producer. When tested under optimised conditions, this strain was able to 
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produce concentrations of 16.7 g L -1 butanol, 4.4 g L -1 acetone, and 2.6 g L -1 ethanol 
(Harris et al., 2000).  
 
In addition to over expression and gene knockouts, the use of technology for the disruption 
of genes without the need for full knockouts has been investigated. First of the technologies 
tested was anti-sense RNA (asRNA). The use of asRNA was first used to test its 
effectiveness in the reduction of the genes involved in butyrate formation (Desai and 
Papoutsakis, 1999). In this study two asRNA’s were designed, one for the gene buk and 
the other for ptb. This work successfully reduced the butyrate kinase and 
phosphotransbutyrylase activities by 85% and 70%, respectively, with the concentrations of 
solvent and acid production from the asRNA comparable with the previous knockout strains 
(Green et al., 1996). The use of asRNA was also later used to demonstrate that CoA 
transferase was the rate limiting step in acetone production and not acetoacetate 
decarboxylase as previously believed (Tummala et al., 2003). A more recent and modern 
technique for the disruption of desired genes, is through the use of CRISPR interference 
(CRISPRi). This method was used by (Woolston et al., 2018) for the downregulation target 
genes in Clostridium ljungdahlii, an autotrophic Clostridium. CRISPRi was deployed in a 
strain engineered for 3-hydroxybutyrate (3HB) production. Downregulation of 
phosphotransacetylase (pta) with a single sgRNA led to a 97% decrease in enzyme activity 
and a 2.3-fold increase in titre. Unfortunately, acetone production still accounted for 40 % 
of carbon flux. In an attempt to overcome this acetone production, sgRNA downregulation 
of aldehyde:ferredoxin oxidoreductase (aor2) and an additional sgRNA targeted to pta 
reduced overall acetate production from 40 % of the carbon flux to 25 %, which lead to an 
increase in 3HB titre and yield.  
 
Finally, due to the destabilising effects that butanol has on proteins and membrane fluidity, 
another prospective target for metabolic engineering is to engineer strains that have 
increased tolerance to butanol (Ezeji et al., 2010). The solvent tolerance mechanism of 
solventogenic clostridium involves the expression of molecular pumps, chaperone proteins 
such as groES, dnaKJ, hsp18, and hsp90, as well as genes involved in sporulation and fatty 
acid synthesis (Ezeji et al., 2010; Tomas et al., 2004). Tomas et al. were able to increase 
final solvent concentrations by the overexpression of GroES and GroEL heat shock proteins 
as part of the groESL operon (Tomas et al., 2003). When cells were exposed to stress 
conditions, GroES and GroEL assist in the refolding of misfolded proteins. During 
overexpression of the groESL operon, growth inhibition by butanol was reduced by 85 % in 
2 g L -1 butanol and 40 % in 4 g L -1 butanol, compared to the control strain. This increase in 
butanol resistance enabled strains to tolerate solvent titres that were elevated by 33 %. 
Selective enrichment has also been used to try and increase resistance to solvents. 
Microarray analysis revealed that enrichment of a fragment containing the gene ca_c1869. 
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The strain that was responsible for the over expression of the gene ca_c1869 (ca_c1869 
was annotated as a singleton transcriptional regulator) had an 80 % increase in its 
resistance towards butanol relative to the control (Borden and Papoutsakis, 2007).  
 
1.8.2 Engineered C. saccharoperbutylacetonicum N1-4(HMT) strains 
 
Unlike the more well characterised strain C. acetobutylicum, C. 
saccharoperbutylacetonicum N1-4(HMT) is a relative new comer to the world of industrial 
ABE production. First discovered in 1969 (Hongo and Ogata, 1969) the full genome 
sequence of the strain was not published until 2014 (Poehlein et al., 2014). Throughout the 
year’s fermentation experiments using a wide verity of feedstocks have been carried out 
using this known butanol hyperproducing strain (Noguchi et al., 2013; Tashiro et al., 2007, 
2004)(Al-Shorgani et al., 2012b). Early investigative work demonstrated that unlike C. 
acetobutylicum strains, cell degradation did not come from loss of the sol genes but more 
so from the breakdown of the regulation of the sol operon and upstream proteins in the 
system (Kosaka et al., 2007). Further to this, the mega plasmid found in C. 
saccharoperbutylacetonicum N1-4(HMT) has also been linked to ester production of butyl 
acetate and butyl butyrate (Gu et al., 2019) . Recently the development of CRISPR/Cas 
based tools for the genetic manipulation of C. saccharoperbutylacetonicum N1-4(HMT) has 
been established (Jenkinson et al., 2015; Wang et al., 2017a), with both systems published 
working by means of a counter-selection method to screen against homologous 
recombination events (Section 1.7.3). A large majority of the published strain engineering 
in this strain has been carried out by the Wang group from the University of Auburn. The 
group have carried out a number of strain metabolic engineering experiments in C. 
saccharoperbutylacetonicum N1-4(HMT). To better understand the butanol production 
mechanism of the strain, the key biosynthetic genes (either endogenous or exogenous) 
including the sol operon (bld-ctfA- ctfB-adc), adhE1, adhE1D485G, thl, thlA1V5A, thlAV5A and 
the expression cassette EC (thl-hbd-crt-bcd) were over- expressed in the strain (Wang et 
al., 2017b). Overall over expression of the sol operon resulted in a 400% increase in the 
production of ethanol with the highest increase in butanol (13.7 %) seen in the strain with 
the over expression of the EC cassette. In an attempt to better understand and elevate the 
process of CCR, the group inactivated the sucrose metabolic pathway by inactivation of the 
gene scrO, doing this resulted in a decrease sucrose consumption by 28.9% and a 
decrease in ABE production by 44.1% using sucrose as the main carbon source. 
Additionally, deletion of the gene scrR alleviated  CCR in the glucose/sucrose mixed 
fermentation; and over expression of the endogenous sucrose pathway resulted in 
increased ABE production (Zhang et al., 2018). (Atmadjaja et al., 2019) have demonstrated 
that it is possible to use the CRISPR/Cas technology for the creation of successful single 
nucleotide polymorphisms (SNPs), deletion and integrations within the genome of C. 
saccharoperbutylacetonicum N1-4(HMT).  
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1.8.3 Alternative butanol producing strains.  
 
An alternative to metabolic engineering the Clostridium spp. directly is to bypass the species 
all together and produce n-butanol in other organisms circumventing many of pitfalls of the 
species. These circumvention tactics have typically involved the heterologous expression 
of the butanol production machinery from Clostridium into strains such as E .coli and S. 
cerevisiae (Fisher et al., 2014; Iddar et al., 2002; Kutty and Bennett, 2007; Morimoto et al., 
2005) as they typically are more well-studied and more genetically accessible than 
Clostridium. However, these organisms typically are more sensitive to butanol 
concentrations in their media as well as a narrower substrate range amongst other issues 
(Luttke-Eversloh and Bahl, 2011). Despite these drawbacks, studies in E. coli from (Atsumi 
et al., 2008), (Inui et al., 2008) and (Nielsen et al., 2009) were able to successfully detect 
butanol production in concentrations of 550 mg L -1 , 1200 mg L -1 and 520 mg L -1  
respectively. Finally, due to the powerhouse of reduction that solventogenic Clostridium are 
known for, similar to butanol production, introduction of genes from Clostridium have been 
introduced into E. coli in a bid to alter the reducing potential within E.coli (Iddar et al., 2002; 
Klein et al., 2010)   
 
1.9 Aims of the Thesis 
 
The research outlined in this thesis can be split into two major sections with the first section 
focusing on the design and construction of a cost effective, expandable, and easy to run 
fermentation system that enables like for like growth conditions that are found in industry 
leading fermentation systems. The second part focusing on improving the solvent producing 
capabilities of C. saccharoperbutylacetonicum N1-4(HMT) by the deletion of the gene gapN, 
deletion of gapN gene was achieved using proprietary CRISPR/Cas tooling known as 
CLEAVE developed by Green Biologics Ltd. Deletion of gapN was carried out as a means 
of recovering ATP that would otherwise be lost by transcription of the GAPN enzyme in C. 
saccharoperbutylacetonicum N1-4(HMT).  
 
As part of the Shepherd lab fermentation testing, buffering compounds CaCo3 and MES 
‘goods buffer’ were tested with MES coming out as the pH buffering compound of choice 
due to its ability to effectively buffer the pH of the acids produced during fermentation, as 
well as its ability to dissolve easily into solution, something that CaCO3 was unable to do. 
Successful culturing of C. saccharoperbutylacetonicum N1-4(HMT) was carried out using 




The final section of this thesis focuses on the construction of the ∆gapN mutant C. 
saccharoperbutylacetonicum N1-4(HMT) strain and the characterisation of the phenotype 
differences of of this strain compared to the wild type during fermentation. One of the main 
hypotheses in the deletion of the gapN gene was that there would be an increase in the 
internal concentrations of ATP which would result in increased concentrations of solvents 
acetone and butanol. Increased solvent production was hypothesised through the deletion 
of gapN as acid production in acidogensis is responsible for generating a large 
concentration of the intracellular ATP, this in turn is then used for solvent production. 
Deletion of the gene gapN and the subsequent loss of GAPN in glycolysis would result in 
increased ATP concentrations which can then be used for solvent production, additionally, 
a decrease in acid production was expected to occur as the cell no longer needs to produce 




Chapter 2  
 
Materials and Methods 
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2.1 Bacteriology Methods  
 
2.1.1 Bacterial strains and plasmids 
 
A list of all of the bacterial strains, plasmids this study can be found in Table 2.1 and Table 
2.2 respectively. Clostridium strains were cultured in Reinforced clostridium media (RCM) 
(sigma 27546-500G-F) that was made anaerobic by autoclaving at 121 oC at 15 psi for 20 
min in serum bottles sealed with butyl stoppers. Depending upon starter culture needed for 
an experiment either 30 mL or 100 mL of RCM was inoculated with 500 µL of 15% (v/v) 
glycerol stocks of C. saccharoperbutylacetonicum N1-4(HMT) and grown statically at 32 oC. 
E. coli strains were grown aerobically at 37 oC and shaken at 180 rpm in Luria-Bertani (LB) 
media. Starter cultures for E. coli growth were taken from single colonies plated out in LB 
agar plates. 
 
Table 2.1 Bacterial Strains and Plasmids used in Thesis 








endA1, recA1, gyrA96, 
thi, hsdR17 (rk–, mk+), 
relA1, supE44, Δ( lac-
proAB), [F´ traD36, 
proAB, laqIqZΔM15]. 
Promega 
Turbo Genotype: F' 
proA+B+ lacIq 
∆lacZM15 
/ fhuA2  ∆(lac-
proAB)  glnV galK16 
galE15  R(zgb-




DH5! genotype: fhuA2 
Δ(argF-lacZ)U169 
phoA glnV44 Φ80 
Δ(lacZ)M15 gyrA96 
recA1 relA1 endA1 thi-






Table 2.2 Plasmids used in the thesis 
Name Characteristic  Source or reference  
PMTL Shuttle Vector System 
PMTL82154 Shuttle vector used in the construction of the 
homologous recombination vector. Contains 
Gram-positive origin (pBP1) element, 
antibiotic resistance marker (catP), gram 
negative replicon (ColE1 + tra) and a CatP 
reporter complex.   
GBL, Clostron (Heap et 
al. 2009)  
PMTL83251 
+Ldr 
Shuttle vector used in the construction of 
killing vector. Contains Gram-positive origin 
(pCB102), antibiotic resistance maker 
(emrB), gram negative replication (ColE1 + 
tra) and a MCS with the addition of the native 
leader sequence from the C. 
saccharoperbutylacetonicum N1-4(HMT) 
CRISPR/Cas system. 
GBL, Clostron (Heap et 
al. 2009)  




Plasmid containing the spacer (Spcr), direct 
repeat (dr), spacer (Spcr) element that is 
blunt ligated into the killing vector. Vector 
additionally contains, gram negative replicon 





All oligonucleotides used in this study are listed in Table 2.3. Oligonucleotides were 
designed using Benchling (https://www.benchling.com/). Each pair of primers were 
designed with less than 5°C difference in melting temperature (Tm) and less than a 5% 
difference in their GC content. Oligonucleotides were synthesised by Eurofins MWG.  
 
2.1.3 Chemicals and water 
 
All chemicals were purchased from sigma unless stated otherwise. Nutrient Agar, tryptone, 
yeast extract were all purchased from OXOID. Throughout distilled water was used for most 
experiments that did not require a high level of purity. For experiments that required a high 
level of purity, Milli-Q water was used. Solutions were sterilised by either autoclaving at 121 




2.2.1 Luria-Bertani medium 
 
Luria-Bertani medium (LB) was prepared as described by Sambrook et.al.; (1987). The 
media consisted of 10 g sodium chloride (Fisher Scientific), 10 g peptone (Difco 
Laboratories), 5 g yeast extract and made up to 1 L with distilled water. Media was sterilised 
by autoclaving at 120 oC at 15 psi for 20 min.  
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LB agar was prepared by the addition of 1% (w/v) number 2 agar (Oxiod scientific) to LB 
medium and then autoclaved as before.  
 
2.2.2 Reinforced Clostridium Medium 
 
Reinforced Clostridium Medium (RCM) (Oxoid Scientific) consisted of 0.5g Agar, 0.5g L-
Cysteine hydrochloride, 5 g D(+)-glucose, 10 g meat extract, 5 g peptone, 3 g sodium 
acetate, 5 g sodium chloride, 1 g starch, 3 g yeast extract and made up to 1 L with distilled 
water. RCM was sterilised by autoclaving at 120 oC at 15 psi for 20 min.  
 
2.2.3 Yeast extract tryptone media 
 
Yeast extract tryptone media (YETM) consists of 40 g L-1glucose, 2.5 g L-1 yeast extract, 2.5 
g L-1 tryptone, 0.5 g L-1 ammonium sulphate and 0.025 g L-1 iron sulphate. YETM was 
sterilised by autoclaving at 120 oC at 15 psi for 20 mins. 
 
2.2.4 X2 CGM Media 
 
X2 stock GCM consists of 5.0g Yeast Extract, 0.75g Dipotassium Phosphate, 0.75g 
Monopotassium phosphate, 0.4g Magnesium sulphate, 0.01g Iron sulphate, 0.01g 
Manganese sulphate, 1 g sodium chloride, 2 g ammonium sulphate, 2 g Asparagine and 
made up to 500 mL with distilled water. Media was sterilised by autoclaving at 120 oC at 15 
psi for 20 min.  
 
LB x2 CGM is prepared as above but with the addition of 7.5 g agar (oxiod scientific) and 
made up to 500 mL. Media was sterilised by autoclaving at 120 oC at 15 psi for 20 min and 
then left at room temperature to set.  
 
2.2.5 10% Sugar Stocks 
 
10% Sugar stocks were made up in 500 mL and sterilised by autoclaving at 121 oC at 15 psi 




2.2.6 X1 CGM Media 
 
A bottle of 10% sugar is decanted into a bottle x2 CGM media. This now gives x1 CGM 
media with 5% sugar. X1 CGM agar is prepared in a similar way to x1 CGM minus agar, 
however prior to addition of 10% sugar the x2 CGM agar is melted in a microwave, and 
10% is only added to solution when it is cool enough to be handled without thermal 
protection.  
 
X1 CGM agar is prepared similar to x1 CGM minus agar, however prior to addition of 10% 
sugar the x2 CGM agar is melted in a microwave, 10% is only added to solution when it is 
cool enough to be handled without thermal protection.  
 
2.2.7 Electroporation buffer with salt 
 
Electroporation buffer with salt (EPB_S) consists of 300 mM sucrose, 0.6 mM sodium 
phosphate dibasic, 4.4 mM monosodium phosphate, 10mM magnesium chloride. Sucrose 
was sterilised by autoclaving at 121oC at 15 psi for 20 min. Sodium phosphate dibasic and 
monosodium phosphate were made into a phosphate stock. Phosphate stock buffer was 
then sterilised by 0.45 µM filter sterilisation. Magnesium chloride was sterilised by 
autoclaving at 121oC at 15 psi for 20 min. pH was adjusted to pH 6.0. Buffer components 
were assembled aseptically.  
 
2.2.8 Electroporation buffer without salt 
 
Electroporation buffer with salt (EPB_NS) consists of 300 mM sucrose, 0.6 mM sodium 
phosphate dibasic, 4.4 mM monosodium phosphate. Sucrose was sterilised by autoclaving 
at 121oC at 15 psi for 20 min. Sodium phosphate dibasic and Monosodium phosphate were 
made into a phosphate stock. Phosphate stock buffer was then sterilised by 0.45 µM filter 
sterilisation. pH was adjusted to pH 6.0. Buffer components were assembled aseptically.  
 
2.2.9 SOB Media 
 
SOB media contained the following: 20 g tryptone, 5 g yeast extract, 0.548 g sodium 
chloride and 0.186 g potassium chloride added to 990 mL of distilled water and autoclaved. 
Once cooled to room temperature 10 mL of 0.2 µm filter sterilised 2 M magnesium chloride 
was added.  
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2.2.10 SOC Media 
 
To prepare SOC media, 20 mL of autoclaved 1 M glucose stock was added to 980 mL of 
SOB media.  
 




Media were supplemented, were indicated, with Thiamphenicol (75 µg mL -1), 
Spectinomycin (250 µg mL -1), Erythromycin (100 µg mL -1 liquid and 40 µg mL -1 Solid) or 
chloramphenicol (25 µg mL -1).    
 
2.3.2 -(N-Morpholino) ethanesulfonic acid 
 
2-(N-Morpholino) ethanesulfonic Acid (MES) (Millipore Corp. Cat: 475893-500GM) was 
used in fermentations at a concentration of 0.1 M as a buffering agent for pH control. MES 
was added to fermentation media and sterilised with the media by autoclaving at 121 oC at 
15 psi for 20 min.  
 
2.3.3 Calcium Carbonate 
 
Calcium carbonate (5 g L -1) was used during fermentation as a buffering agent in the control 
of pH. Calcium carbonate was added to media and sterilised with the media by autoclaving 
at 121 oC at 15psi for 20 min.  
 
Table 2.3 Oligonucleotides used in this study 
Name Sequence  Description of Function 
HR_F1 5’ – ATAATGCTTGCTATTCTAGG – 3’ 
 
First forward primer used 
in the amplification of one 




AGTTGCTTTATTTTCACCTCTATCCATTG – 3’ 
 
Frist reverse primer used 
in the implication of one 







Second forward primer 
used in the amplification 




5’ – AGCTACTTCCATATCAGAAAATTG -3’  
 
Second reverse primer 
used in the amplification 
of one of the HR 1kB 
fragments. 
M13F 5’ - TGTAAAACGACGGCCAGT – 3’ 
 
M13 Primers were used 
to amplify regions of 
interest in the pMTL80k 
plasmids that fell 
between M13F and 
M13R 
M13R 5’ – CAGGAAACAGCTATGAC – 3’  
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2.4 Culture conditions  
 
2.4.1 E. coli 
 
10 mL starter cultures were inoculated from a single colony on an agar plate. Cells grown 
up aerobically overnight in LB (37 oC and 180 rpm). A 1% inoculum from the overnight was 
as starter culture when inoculating fresh media. Liquid E. coli cultures were grown in a New 
Brunswick™ Innova® 3100 water bath at 37°C and 180 rpm in 50 mL conical flasks 
containing 10 mL of LB medium, unless otherwise stated. 
 
2.4.2 Preparation of glycerol stocks 
 
Glycerol growth stocks of Clostridium were prepared by mixing 750 µL of 50% (v/v) glycerol 
with 750 µL of an overnight culture. Glycerol Stocks of C. saccharoperbutylacetonicum N1-
4 were prepared by mixing 750 µL of 30% (v/v) glycerol with 750 µL of C. 
saccharoperbutylacetonicum N1-4 at an OD600 of between 1.8 and 2.2. Stocks were stored 
at -80oC.  
 
2.4.3 Culture optical density 
 
The optical density of cultures was measured at 600 nm (OD600) using a Shimadzu UV-
1800 spectrophotometer in cuvettes with a 1 cm path length. 
 
2.4.4 Butanol Toxicity  
 
To test butanol toxicity the Clostridium cells were first inoculated from 15 % glycerol stocks 
into 30 mL of RCM in 30 mL serum bottles overnight. Following this, a 1 /10 dilution of the 
overnight cultures was used to inoculate YETM media containing 40 g L -1 glucose. Cells 
were left to grown for 4 h to maintain a stable OD600. Once cells had reached an OD600 of ~ 
2 they were challenged with various percentages v/v of butanol ranging from 0.5-5 %. Once 
challenged, growth of the cells was monitored to see the impact on butanol toxicity on 
growth rates.  
 
2.4.5 Seeding of Clostridium 
 
To be able to carry out fermentation experiments at the required volumes, the correct 
volume of inoculum was required in the correct media. This was achieved by growing C. 
saccharoperbutylacetonicum N1-4 firstly overnight between 18-24 h in 30 mL or 100 mL 
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RCM at 32 oC in serum bottles. From here, a 10% inoculum from the RCM overnights was 
used to inoculate 100 mL of the fermentation media in serum bottles. This was left overnight 
for 16-18 h at 32 oC. From here, the overnights in the correct media were used as a 10 -15 
% inoculum into fermentation media at the required volume for the fermentation. Cells were 
monitored until the OD600 reached a value of around 1.8-2.5. Once this was achieved the 



























2.5.1 Batch Fermentation – University of Kent Set up 
 
Batch fermentation was carried out in 1 L culture vessels (SciLabware, Pyrex Quickfit) with 
a 500 mL culture volume at 32oC.  Fermentation media consisted of a yeast extract tryptone 
media (YETM) (40 g L-1glucose, 2.5 g L-1 yeast extract, 2.5 g L-1 tryptone, 0.5 g L-1 
ammonium sulphate and 0.025 g L-1 iron sulphate) at pH 6.2, supplemented with 0.1 M MES 
free acid (Merck, 475893) for pH control during fermentation. Anaerobic conditions in the 
fermentation were generated by sparging filtered (0.2 µm pore size) oxygen-free nitrogen 
through the fermentation media for 20 min pre-inoculation and then 5 min post-inoculation. 
Seed cultures were established by growing recovered RCM grown cells, in 80 mL YETM in 
serum bottles overnight to an OD600 of ~4.0. The final fermentation inoculation was 10% 
(V/V). Fermentations were carried out in triplicate. 
 
Day 3 – 5: 
5ml Sample taken.  
Every 3hrs over 48h 
Figure 2.1 Seed train for Clostridium fermentation. This seed strain was 
used for fermentation experiments and allowed for establishment of a healthy 
starter culture for fermentation experiments.  
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Throughout fermentation OD600 (Agilent technologies Cary 60 uv Vis), pH (Mettler Toledo, 
InLab pH) and redox potential (Mettler Toldeo, InLab Redox Micro) of the fermentation 
media was measured. Following measurement, supernatant and cells were separated by 
centrifugation at 8000 rpm for 10 min. Supernatant and cell pellet were separated and 
frozen at -80 oC for later use 
 
 
2.5.2 Batch Fermentation – GBL 
 
Batch fermentation was carried out in 2 L fermentation vessels (Electrolabs fermac 200) 
with a fermentation volume of 500 mL. Fermentation media consisted of a yeast extract 
tryptone media (YETM) ( 2.5 g L-1 yeast extract, 2.5 g L-1 tryptone, 0.5g L-1 ammonium 
sulphate and 0.025 g L-1 iron sulphate), supplemented with 0.1 M MES free acid (Merck, 
475893) for pH control during fermentation Anaerobic conditions in the fermentation were 
generated by sparging (0.2 µM pore size) filtered oxygen free nitrogen through the 
fermentation media for 1 h pre-inoculation at a rate of 1L min -1.  Fermentation sugars 
totalled 50 g L -1 consisting of 11 g L -1 glucose, 14 g L -1 xylose, 4.65 g L -1 galactose, 1.95 
g L -1 and 18.4 g L -1 mannose.  
 
2.5.3 Fed Batch Fermentation – GBL  
 
Fed batch fermentation was carried out in 2 L fermentation vessels (Electrolabs fermac 200) 
with a fermentation volume of 1000 mL. Fermentation media consisted of a yeast extract 
tryptone media (YETM) (50 g L-1 glucose, 2.5 g L-1 yeast extract, 2.5 g L-1 tryptone, 0.5 g L-
1 ammonium sulphate and 0.025 g L-1 iron sulphate), with a starting pH of 5.3. The pH was 
maintained via the addition of ammonium hydroxide (Fermac 260 pH controller) and 
fermentation media was agitated at 50 rpm throughout. The process of fed batch first 
involved an initial batch fermentation to allow sugars to drop to below 15 g L -1 and for cell 
culture to reach a high density. Following this initial batch fermentation, gas stripping 
(Section 2.5.4) was initiated to enable removal of solvents, preventing them reaching toxic 
concentrations. In addition to this, cell feeding was initiated. The media fermentation media 
was used as the media for feed. Feeding rate was altered throughout to maintain sugars 
below 15 g L -1 while still maintaining gas stripping.  
 
2.5.4 Gas Stripping – GBL 
 
To maintain non-toxic levels of solvents throughout the fed batch fermentation, 0.2 µM 
filtered N2 was bubbled through the fermentation media at a rate of x3 the fermentation 
volume per minute which in our case was 3 L min -1. Evaporated gases were not collected.  
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2.6 Genetic Methods  
 
2.6.1 Isolation of plasmid DNA 
 
Plasmid DNA was isolated using QIAprep Spin Miniprep Kit (QIAGEN) according to 
manufacturers’ instructions. Overnight cultures were pelleted at 5000 x g for 10 min 
using a Sigma Laboratory Centrifuge 2k15. Following this first stage, all further 
centrifugation was carried out at 16000 x g in an Eppendorf 5415R micro centrifuge. 
 
2.6.2 Polymerase chain reaction (PCR) 
 
A number of different PCR reactions were carried out throughout the project. For E. coli 
colony PCR reactions (CPCR), a small fragment of a colony was taken with a sterile pipette 
tip and mixed directly into the pre-assembled reaction. For PCR reactions from isolated 
genomic material, firstly the genomic material was quantified using a nanodrop. Following 
quantification, <1000 ng of DNA was added to the pre-mixed PCR reaction mix. For 
Clostridium CPCR reactions, the colonies are first exposed to a lysis step. This lysis step 
involves a scrape of a colony being add to a lysis solution consisting of 0.25 µL of 20 mg 
ml -1 proteinase K  and 24.75 µl TE buffer pH 8.0. Following addition of colony and prior to 
CPCR, lysis PCR reaction was carried out, shown in Table 2.4 All PCR reactions carried 
out at the university of Kent used the 2x Q5 master mix (NEB) reaction mix shown in Table 
2.5. 2x Q5 reactions are shown in Table 2.6 For all PCR reactions carried out at GBL 
Phusion polymerase mixture was used, reaction mixture Table 2.7 and experiment 
conditions Table 2.8 for Phusion are shown below.   
 
Table 2.4 Lysis PCR reaction for Clostridium PCR  
Temperature (oC) Time (Min) 
55 15  
80 15 
10 Final hold 
 
Table 2.5 2x Q5 Master Mix PCR reaction mixture  
Component 25 µl Reaction 50 µl Reaction Final Concentration 
Q5 High-Fidelity 2X Master Mix 12.5 µl 25 µl 1X 
10 µM Forward Primer 1.25 µl 2.5 µl 0.5 µM 
10 µM Reverse Primer 1.25 µl 2.5 µl 0.5 µM 
Template DNA variable variable < 1,000 ng 





Table 2.6  2x Q5 PCR reaction  
STEP TEMP TIME 
Initial Denaturation 98°C 30 s 
25–35 Cycles 
98°C 5–10 s 
*50–72°C 10–30 s 
72°C 20–30 s/kb 
Final Extension 72°C 2 min 
Hold 4–10°C   
 
 
Table 2.7 – Phusion PCR reaction mixture 
Component 20 µL Reaction 50 µL Reaction Final Concentration 
Nuclease-free water to 20 µL to 50 µL   
5X Phusion HF or GC Buffer 4 µL 10 µL 1X 
10 mM dNTPs 0.4 µL 1 µL 200 µM 
10 µM Forward Primer 1 µL 2.5 µL 0.5 µM 
10 µM Reverse Primer 1 µL 2.5 µL 0.5 µM 
Template DNA variable variable < 250 ng 
DMSO (optional) (0.6 µL) (1.5 µL) 3% 
Phusion DNA  
Polymerase 0.2 µL 0.5 µL 1.0 units/50 µL PCR 
 
Table 2.8 – Phusion PCR reaction 
STEP  TEMP  TIME  
Initial Denaturation  98°C  30 s  






15-30 s/kb  
Final Extension  72°C  5-10 min  






2.6.3 DNA electrophoresis on agarose gels 
 
1 % (w/v) agarose gels were prepared and ran in 1 x TEA buffer and electrophoresis was 
carried out using gel apparatus at 80 V 300 mA for 45 min to 1 h depending upon fragment 
size. Samples were mixed with a 6x blue/orange loading dye (Promega). A 1 kb DNA ladder 
(Promega) was used for Kent samples or 1 kb gene ruler (Thermo) for GBL samples. 
Following running of the gel, DNA samples in the gels were stained with 100 mL of 0.5 mg 
mL -1 ethidium bromide (in water) and visualised on a UV box. 
 
2.6.4 Preparation of E. coli competent cells   
 
E. coli from overnight cultures were used as a 1% (V/V) inoculum into 100 ml of fresh LB. 
These fresh inoculations were left to aerobically grow at 37 oC shaking at 180 rpm until 
OD600 reached 0.4 – 0.5. When optimum OD600 was reached, cells were immediately put on 
ice for 30 minutes, once the 30 minutes was up, the cells were centrifuged at 2300 xg for 5 
min to pellet the cells. The pelleted cells were then resuspended in 10 ml of pre-chilled ice 
cold 100 mM CaCl2 and left for 2 h. Once the two hours had passed, the cells were pelleted 
again, and then resuspended in 2 ml ice cold 100 mM 30% glycerol and snap frozen in a 
dry ice ethanol bath and stored at -80 oC for future use. Cells were kept a maximum of 6 
months as to not lose competency.   
 
2.6.5 DNA ligations 
 
Sticky end ligations 
 
Following digestion of both the desired insert and plasmid with compatible sticky end 
enzymes, a reaction mixture of 50 ng total vector backbone was mixed with varying molar 
ratios of insert at 1:1, 1:3, 1:5. Following mixing, 2 x rapid ligation buffer (Promega) was 
added alongside 2 µL of T4 Ligase (Promega) and total volume made up to 20 µL. Following 
this, reactions were incubated at 22 oC for 2-3 h or overnight at 4 oC and then transformed 
into a variety of chemically competent E. Coli cells. A vector cut with a single sticky end 
enzyme was also ligated and transformed during these experiments as a positive control.  
 
Blunt end Ligations 
 
Following identification of a blunt end restriction sites in the plasmid of choice, successful 
PCR amplification of insert and clean-up of DNA was then used to calculate molar ratios of 
vector to insert similar to stick end ligation, ratios: 1:1, 1:3 and 1:5 were calculated. Once 
molar ratios were calculated 50 ng of Vector, the required volume of PCR insert for correct 
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molar ratio, 5 µL of x 2 rapid ligation buffer (Promega), 0.5 µL of blunt cloning enzyme of 
choice were added to a PCR tube and made up to 9 µL with nuclease free water. Once 
assembled, reaction was incubated in thermos cycler for 30 min to allow optimum digestion 
of plasmid. When digestion is complete, 1 µL of T4 Ligase was added to the reaction 
mixture, reaction was then returned to incubation in the thermo cycler for 3 h at 22 oC. 
Finally, after the 3 h incubation was finished 2 µL of x10 cutsmart buffer (NEB), 0.5 µL blunt 
enzyme of choice (NEB) and 7.5 µL of nuclease free water were added to the reaction and 
left to incubate for 1 h at 37 oC. Following this incubation, 5 µL of final blunt mixture was 




Using the NEBioCalulator (http://nebiocalculator.neb.com/#!/ligation) the correct pmol 
concentration of vector and insert were calculated to ensure maximum success. For the 
Gibson assembly concentrations of between 0.02 – 0.5 pmol are required for an optimal 
reaction.  Following these calculations, the inserts and vectors were added to 10 µL 2 x 
Gibson assembly master mix and then incubated in a thermocycler at 50 oC for 1 h. 
Reactions after incubation were stored at -20 oC or 2 µL of assembled reaction was 
transformed into chemically competent E. Coli.  
 
2.6.6 Transformation of E.coli competent cells 
 
Plasmid DNA (2-5 µL) or reactions from Gibson assembly or ligations were mixed with 50 
µL of competent E. coli cells and incubated on ice for 30 min. Cells were then heat shocked 
for 45 s at 42 oC and then immediately placed on ice for 2 min. 200 µL of SOC media was 
added and the cells were left to recover at 37 oC shaking at 200 rpm for 1 h. The cells were 
then spread onto LB agar plates (containing appropriate antibiotic), and left to grow for 






2.6.7 Clostridium transformations 
Day 1:  
54 mL of 1 x GCM glucose media was aliquoted into a 250 mL flask along with 10 
mL of the same media into a 50 mL sterile universal tube. The aliquoted 1 x CGM glucose 
media was transferred into the anaerobic chamber (Whitley A85TG Workstation) along with 
1 mL aliquots of EPB_S and 50 mL of EPB_NS (Section 2.1.4.8) and left overnight to 
equilibrate with the anaerobic atmosphere. Alongside media, overnight cultures of C. 
saccharoperbutylacetonicum N1-4(HMT) were prepared from glycerol stocks (Section 
2.4.2). Glycerol stocks were inoculated into either 30 mL or 100 mL RCM and then left to 
grow overnight at 32 oC.  
 
Day 2: 
The overnight cultures that were grown in either 30 mL or 100 mL RCM serum 
bottles (Section 2.2.2) were degassed prior to aliquoting. Degassing involves piercing of the 
rubber septum of the serum bottle using a needle and syringe that has had the plunger 
removed. Degassing decreases the internal pressure within the serum bottle for safe 
removal of the metal cap and rubber septum. The degassing of the overnight cultures was 
carried out outside of the chamber. Following degassing 10 mL of the overnight culture was 
transferred to a 50 mL universal tube (this was done outside of the chamber). The 50 mL 
universal tube containing 10 mL of overnight culture was transferred to the anaerobic 
chamber where 6 ml of the overnight culture was used to inoculate the 54 ml of 1 x GCM 
from left to equilibrate in the chamber overnight from day 1. This culture was grown at 32 
oC in the anaerobic chamber until the OD600 reached 1.2. 25 mL of this culture was then 
decanted into 2 x 50 mL falcon tubes, which were placed on ice to cool for 15 min. After 15 
min, cells were centrifuged at 4000 xg and 4 oC for 10 min. The pelleted cells were 
transferred back into the anaerobic chamber, the supernatant was discarded, and 20 mL of 
EPB was used to resuspend one of the cell pellets. These resuspended cells were 
transferred into the second falcon tube and the second pellet was resuspended. Following 
resuspension, cells were centrifuged at 4000 xg and 4 oC for 10 min and the supernatant 
was discarded. The cell pellet was placed on ice immediately and then resuspended in 1 
mL EPB_NS. After resuspension, 200 µL of EPB_NS suspended cells were transferred to 
electroporation cuvettes that were pre-chilled on ice containing the correct amount of DNA 
(Appendix D) for electroporation and left on ice to chill for 5 min. The electroporator 
delivered 1.5 kV to the cuvette, and immediately following electroporation 1 mL of 1 x GCM 





Day 3 – 7:  
After recovering overnight, 200 µL of cells were plated out onto GCM agar containing 
the correct selective antibiotic and left for between 48 – 72 h to allow for the appearance of 
Clostridium colonies. After colonies appeared, a single colony was taken and CPCR was 
carried out to check for the correct plasmid. Following identification of the correct plasmid, 
the colony was grown overnight in 10 mL RCM at 32oC overnight inside of the anaerobic 
chamber, the following day subsequent 15% glycerol stocks (Section 2.4.2) were made and 





CLEAVE is CRISPR/ Cas technology developed by Green Biologics limited (Jenkinson 
et al., 2015). Overview of functionality is described in Chapter 4. 
 
2.6.9 Sequencing of DNA  
 
To confirm successful mutagenesis DNA samples were sequenced by Eurofins and the 
data was analysed using Benchling (https://www.benchling.com/). For whole genome 
sequencing libraries were prepped using Nextera® XT DNA Library Prep Kit from Illumina® 
following the manufacturer’s instructions. Library preparations were then sequenced using 
an Illumina® MiSeq benchtop sequencer using a MiSeq reagent kit v3.  
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2.8 Biochemical Methods 
 




The extraction technique from Beri et al., (2016) was used. 2 mL from exponentially growing 
and stationary phase culture was added to 1 mL of 1 M HCL for NAD(P)+ extraction and 1 
mL of 1 M KCL for NAD(P)H extraction. Cells were incubated at 55oC for 10 minutes. 
Following incubation, the pH of the samples was neutralised to pH 6.5 for acid samples and 
pH 7.5 for base samples. This was achieved by adding 1 M HCL and 1 M KCL dropwise 
with continual vortexing. After neutralisation, samples were centrifuged for 15 min at 4400 
x g, with the supernatant following centrifugation being saved for subsequent analysis. Two 
biological repeats and two technical repeats of each biological repeat were taken.  
 
Quantitation of NADH and NADPH 
 
Concentrations of NADH and NADPH were measured using previously described methods 
(Baker, 2016; Bernofsky and Swan, 1973; Nisselbaum and Green, 1969). In brief, the 
reaction mixture for the NADH assay consisted of 100 µL 1M tricine-NaOH (pH 8), 100 µL 
40mM EDTA, 100 µL 0.1 M NaCl, 100 µL 4.2 mM MTT, 100 µL 16.6 mM PES, 100 µL 100 
% EtOH . The reaction mixture for NADPH assay consisted of 100 µL 1M tricine-NaOH (pH 
8), 100 µL 40mM EDTA, 100 µL 0.1 M NaCl, 100 µL 4.2 mM MTT, 100 µL 16.6 mM PES, 
100 µL 10 mM Glucose-6-phospahte.  500 µL of each of the assay mixture was added to 
100 µL of extracted sample, topped up to 900 µL with 0.1 mM NaCl and incubated at 37 oC 
(change to oC throughout) for 5 min. To generate standard curves, similar reactions were 
set up where the extracted sample was replaced with nucleotide solutions of known 
concentration. 100 µL of Alcohol dehydrogenase and 100 µL Glucose-6-phosphate 
dehydrogenase were then added at 10 U of enzyme per reaction. The reaction was 
incubated at 37 oC for 1 h in the dark. 500 µL of 5 M NaCl was then added to stop the 
reaction and precipitate MTT. Samples were centrifuged at 4oC and x10,000 g for 5 min. 
Supernatants were decanted and the MTT pellets were resuspended in 1 mL of ethanol, 







2.8.2 ATP Luminescence assay 
 
ATP was quantified in cells grown anaerobically in P2 minimal media (Baer et al., 1987) 
















0.000001 0.00001 0.0001 0.001 0.01 0.1 1 10 100
RL
U
Final concentration in Media (µM)
Figure 2.3 ATP standard curve diluted in YETM media. Relative light units were collected 
with 0.5 sec integration time 
Figure 2.2 (A) NADH and (B) NADPH standard curves. 
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2.8.3 GCMS quantification of acids and solvents 
 
Solvent analysis was carried out using Gas Chromatography Mass Spectrometry (GCMS) 
of the fermentation supernatant samples. Agilent 6890N at the University of Kent was used 
for this. The GC was equipped with 7HG-6013-11 Zebron. Helium (>99.999%) was used as 
the carrier gas, with a constant flow rate of 1 mL -1 minute. A 0.2 µL water sample was 
injected with a 100:1 split. Injection temperature was set to 150oC, the GCMS transfer line 
temperature was set to 280 oC, ion source 230 oC, quadrapole 150 oC. After injection column 
temperature was held at 30 oC for 5 min, following this increased to 150oC at the 20 min 
mark. Compounds were identified by comparing retention times of each of the compounds 
with retention times of reference compounds. 
 
2.8.4 HPLC quantification of sugars (Kent) 
 
Fermentation supernatants were removed from the -20 oC and allowed to thaw to room 
temperature. Once samples had reached room temperature they were homogenised and 
centrifuged at 13400 xg for 5 min. 200 µL of the sample was then added to 600 µL of HPLC 
grade water, achieving a x4 dilution and a total volume of 800 µL. Glucose concentrations 
were measured using cation exchange chromatography. Column used was a phenomenex 
rezex ROA H+ 1 ml minute -1 5 mM sulphuric acid. Samples were run at 60oC and compared 





2.8.5 HPLC quantification of sugars and solvents – GBL  
 
Fermentation supernatants were removed from the -20 oC and allowed to thaw to room 
temperature. Once samples had reached room temperature they were homogenised and 
centrifuged at 13400 xg for 5 min. 200 µL of the sample was then added to 600 µL of HPLC 
grade water, achieving a x4 dilution and a total volume of 800 µL. Prior to addition to HPLC 
tubes, samples were filtered through a 0.2 µm cellulose filter to remove any remaining 
bacteria, ensuring that they are unable to affect the results by still being metabolic active. 
Samples are analysed using Bio Rad Aminex HPX-87H column. Solvents, acids and 
common sugars run under the following conditions Table 2.9.  
 
Table 2.9 HPLC Conditions for Solvents, acids and common sugars: 
 Condition  Setting  
Elution type  Isocratic elution  
Flow rate  0.9 mL/min  
Oven temperature  85 °C  
Run time  Maximum 30 min  
Injection volume  10 μL  
Detector type & detection 
temperature  
Refractive index at 35 °C  
Mobile phase  5 x 10-3 mol/L H2SO4  
Seal wash  10% methanol  
Injector wash  HPLC grade water  
 
2.8.7 Glucometer Sugar measurements 
 
Glucose concentrations were measured during fermentation using a Sinocase Safe AQ 
Smart Blood glucose monitoring system. Samples were taken during fermentation and 
centrifuged at 13400 xg for 5 min. Following separation from the cell mass, a glucose test 
strip was submerged into the supernatant to gain a reading for glucose concentration in 
each sample.    
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2.9 Genomic sequencing and analysis methods 
 
2.9.1 Clostridium Genomic DNA isolation 
 
Genomic DNA was extracted using the GenElute Ô bacterial genomic DNA kit (Sigma 
NA2100-1KT) following manufactures instructions.  
 
2.9.2 Whole Genome sequencing 
 
Whole genome sequencing was carried out using the illumina MiSeq system Genome 
library for both the wild type strain and the ∆gapN were prepared using the Nextera® XT 
DNA Library Prep Kit, which is optimized for small genomes. Once the libraries were 
prepared, they were sequenced using an Illumina MiSeq benchtop sequencer.  
 
2.9.3 Assembly and annotation  
 
Following Illumina® MiSeq, the read quality was assessed with FastQC 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc). To improve read quality 
reads were trimmed using Trimmomatic (Bolger et al., 2014). Trimmomatic improves 
read quality of the illumina reads by removing sequence adapters, trimming bases at 
the beginning and end of the reads if they fall below the stipulated threshold, finally it 
eliminates any of the reads that fall below the minimum read length, which by default is 
set to 36 bp. Following this, reads mapped using BWA (Li, 2013) to the refence genome 
for C. saccharoperbutylacetonicum N1-4(HMT) obtained from Genbank (CP004121.1). The 
quality of the genome maps were  assessed using Qualimap (García-Alcalde et al., 2012).  
Functional annotation was performed using PROKKA (Seemann, 2014) and Roary (Page 
et al., 2015) was used for analysis of gene content and the pangenome. 
 
2.9.4 Variant identification   
 
To asses any variation between the Wild type and ∆gapN C. saccharoperbutylacetonicum 
N1-4(HMT) SNP analysis of the BWA assembled genomes to the reference genome C. 
saccharoperbutylacetonicum N1-4(HMT), Snippy was used 
(https://github.com/tseemann/snippy). In addition to SNP analysis, PROKKA (Seemann, 
2014) was used to annotate the assembled illumina reads and identify properties such as 
tmRNA, CDS, rRNA and tRNA in each of the assembles. Genome alignments were 




Chapter 3  
 
 
Design and construction of fermentation 
platform and establishment of analytical tools 






Clostridium species are known to be difficult to handle due to their anaerobic nature and 
typically require specialist equipment for their culture such as anaerobic chambers, serum 
bottles and fermentation systems. As the overall goal of the project was to optimise solvent 
production in Clostridium spp. we required a three-vessel parallel fermentation system to 
provide consistent culture conditions. To achieve this, a bioreactor was designed and 
constructed that had the capabilities for batch and fed batch processes, and could even be 
set up for continuous fermentation experiments at a fraction of the cost of commercial 
systems. This system has a reduced cost per unit comparatively, and carries over many of 
the same functionality of those systems with a higher price point of entry, including in-line 
monitoring of temperature, pH, redox poise. In future, this system will be of interest to 
researchers in low to middle income counties that require high performance parallel 
fermentation platforms but commercial systems are financially out of reach. 
 
Following instalment of the fermentation system, techniques to analyse the acids, solvents 
and sugars from the fermentation mixture were established allowing for small scale 
fermentation reactions to take place. This allowed for the characterisation of strains to take 
place in a scaled down industrial setting. CaCO3 and MES were compared as buffering 
compounds for controlling the pH of the fermentation, MES provided more accurate 
measurements in comparison to CaCO3 and was chosen preferentially going forward in 
batch experiments. GCMS was established as the preferential method for acid and solvent 
detection. HPLC was used to quantify sugar concentrations of fermentation supernatant 
samples. In addition to this, in keeping with the cost-effective theme of the project, 
glucometers that are typically used for the measurement of blood glucose concentrations 
in diabetics were tested alongside HPLC analysis of glucose. Overall the concentrations of 
glucose measured by the glucometer correlated with around 88% accuracy to the 







For the culture of solventogenic clostridial strains, three main types of fermentation have 
been studied in depth. These are, batch, fed batch and continuous fermentations. Of these 
techniques, batch culture is the quickest and simplest of the three methodologies. Batch 
fermentations start with an initial high concentration of feed. Throughout the process of 
batch fermentation, this feed is metabolised and the production of ABE solvents occurs. 
Batch fermentations have been carried out on a number of species using a number of 
differing feedstocks (Al-Shorgani et al., 2012a; Ellis et al., 2012; Mermelstein et al., 1993; 
Noguchi et al., 2013; Qureshi and Blaschek, 2000). The control of pH is crucial during batch 
fermentations as the drop of pH due to acid production allows for the solventogenic shift to 
occur. However, for optimum solvent production the pH cannot be allowed to drop and 
cause acid crash (Maddox et al., 2000), and the pH also cannot be maintained too high as 
this will lead to inefficient solvent production (Zheng et al., 2015). There are, however, a 
number of drawbacks from batch fermentations. These drawbacks include: (i) inhibition of 
solvent production and accumulation of vegetative cells as a result of butanol toxicity build 
up in the system; (ii) carbon catabolite repression during batch fermentation; (iii) lengthy 
downtime and start up time between fermentation cycles and treatment of fermentation 
media.  
 
Fed-batch fermentations begin with high concentrations of feedstocks. Typically fed-batch 
systems are run initially as a batch fermentation alone, despite using a large majority of the 
feedstock this initial batch will allow for the establishment of a dense culture medium of 
cells. This high density of cells following the batch will be in the solventogenic phase of their 
growth. Once this phase is reached, the cells are fed with additional feedstock to take 
advantage of the cells solventogenic phase for an extended period of time that would not 
be possible in traditional batch fermentations. However, due to the toxicity of solvent 
accumulation, butanol in particular, fed-batch systems have traditionally been investigated 
in tandem with various solvent recovery methods to maximise the solvent production and 
yield during the fermentation process (Jang et al., 2012; Outram et al., 2017; Qureshi and 
Blaschek, 2001, 2000). Finally, continuous fermentation is a chemostat culture whereby the 
concentrations of cells, substrates and products are at a steady state following the gradual 
addition of multiple culture volumes of fresh fermentation broth. One of the main drawbacks 
of continuous fermentation with Clostridium is a low cell count. This has been overcome via 
the use of cell immobilisation in various carriers as well as cell recycling using membranes 
(Tashiro et al., 2013). 
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3.3 Results  
 
3.3.1 Fermenter design and construction 
 
Having the ability to run fermentation experiments is key to better understanding the 
process of the ABE fermentation, as it replicates a scaled down version of what is seen in 
an industrial setting. The fermentation facility will enable the following; (i) characterisation 
of a veriety of growth conditions as well as feedstocks that could be used in an industrial 
setting; (ii) Characterisation of any genetic engineering that is achieved on Clostridium and 
how these changes affect the overall cell life cycle as well as the effects on ABE production 
during fermentation.  
 
One of the main hurdles in establishing a fermentation protocol is the cost of entry per unit. 
Prices for these fermentation units can range from entry at 8000 GBP per unit, to upwards 
of 25,000 GBP per unit (Table 3.1). Knowing this, we set about to establish our own 
fermentation system that could retain as much of the functionality of the commercial units, 
but at a fraction of their cost. Overall, there were 3 main criteria for the fermenters:  
 
1. Flexibility in fermentations style, i.e. batch, fed batch or continuous culture.  
2. Affordable (Cheaper than current market products) 
3. Upgradeable, i.e. new style head gaskets, culture volume change or additional 
probes/electrodes addition. 
 
To ensure that these criteria could be met along with retaining all the required functionality, 
research of commercial fermentation units was carried out. This functionality included 
temperature control to accommodate varying preferential growth temperatures of different 
organisms. Most of the systems researched used either an electric heated jacket system, 
such as the fermac 200 and the F0-Baby, or a jacketed water system like that seen on the 
BioFlo 120 from Eppendorf (Table 3.1). In our system we opted for a water jacketed system 
in which the temperature was controlled via the use of an aquarium heater for tropical fish. 
Doing this enabled us to maintain temperatures between 18-37oC (Appendix A1). 
 
Alongside temperature control, culture agitation was achieved via the use of a magnetic 
stirring bead with the fermenters placed on magnetic stirrers. Redox and pH measurements 
were achieved via the use of the Mettler Toledo InLab probe system, attached to a hand-





Schematics for our fermentation system to be used in batch, fed batch as well as continuous 
were drawn up (Figure 3.1). From here a list of components was established 
 (Appendix A2). Aside from all the purchased components, a custom gas escape/sample 
port had to be constructed, this was achieved by running metal piping at varying lengths 
through rubber bungs and sealing them to ensure airtight. These ports can be seen in 
Appendix A3. Pictures of the final system set ups can be found in (Appendix B), in addition 
to pictures there are a number of videos demonstrating the system functioning and set up 





Table 3.1 Comparison of main functionality of commercially available fermentation systems compared to the Shepherd lab designed system 
Name 
 Electrolab FerMac 200 Eppendorf BioFlo® 120  BioNet F0-BABY  Shepherd Lab Set up 
In Line Functionality 
Temperature control range (oC) 5 – 50 oC 0-70 oC Temp Range not given 18-37 oC 
pH control range 4-10 2-12 2-12 Controlled via buffering agent 
Agitation (rpm) 50 -1100 25 – 1500 0-2000 0-1000 
In line OD measurements Yes - Optional Extra No No No 
Redox (mV) Yes – Optional Probe Yes – (-)2000 – (+) 2000 Yes - Optional probe Yes 
Dissolved O2 0-120% 0 200% Yes – Optional Probe No 
Fermentation type 
Batch Yes Yes Yes Yes 
Fed Batch Yes – Optional extra pump Yes – Built in Yes – Optional extra pump Yes – Optional extra pump 
Continual Yes – Optional extra pump Yes – Built in Yes – Optional extra pump Y – Optional Extra 
Volume Range (L) 2-1000 0.25 – 40 1-5 1 







Figure 3.1 Schematic overview of the shepherd lab fermentation units. A). 
Schematic for batch fermentation system. B). Fed batch schematic. C). 
Continuous culture system.   
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3.3.2 Growth optimisation of C. saccharoperbutylacetonicum N1-4(HMT) 
 
When establishing optimal fermentation conditions, a seeding system was developed 
Figure 2.1, this was used to ensure that a healthy, dense culture of C. 
saccharoperbutylacetonicum N1-4(HMT) was acclimatised in the fermentation media prior 
to fermentation. In total the seeding process took 3 days prior to inoculation into the 
fermenters. It was this seeding procedure that resulted in the highest rate of observed 
fermentation failing. This is an unfortunate result of the difficulties in working with anaerobic 
Clostridium spp. This problem was mitigated throughout by ensuring that over seeding took 
place, whereby a larger number of seeds cultures were started to ensure that enough of the 
starter and seeding cultures were made available come the time of fermentation.  
 
The largest drawback of the current ‘Shepherd Lab’ fermenters is the lack of a pH control 
module that would allow for the addition of acids and alkali to control of pH within a tight 
window. The issue of pH control was largely overcome by the use of buffering agents during 
fermentation. Two buffers, calcium carbonate (CaCO3) and 2-(N-morpholino) 
ethanesulfonic acid (MES Buffer) were tested and compared during batch fermentations.  
 
The buffering action for both CaCO3 and MES are shown in Figure 3.2. Previous studies 
have demonstrated the use of CaCO3 as a buffer during ABE fermentations (Maddox et al., 
2000; Sadie R. Bartholomew, 2006; Yang et al., 2013). The suitability for autoclaving and 
relative affordability makes CaCO3 a strong buffer choice for ABE fermentations. MES 
buffer was first described as part of the Goods buffers (Frederic Monot , Jean-Marc 
Engasser, 1984) and has been shown to be the most effective between the pH ranges 
observed during ABE fermentation, with a pKa value of 6 compared to 9 for CaCO3.  
 
A. CaCO3(s) + 2 H+(aq) → Ca2+(aq) + CO2(g) + H2O(l) 
B. 
 
Figure 3.2 Buffering agents used in ABE fermentation A). Chemical reaction of CaCO3 with acids and 





To test both CaCO3 and MES as buffering agents, batch fermentation experiments in YETM 
40 g L -1 glucose were carried out, batch fermentation conditions were kept the same in 
both experiments with the only variable being MES and CaCO3 in each. Both MES and 
CaCO3 were able to adequately buffer the pH during a batch fermentation Figure 3.3B 
avoiding a drop in pH below 5 that would result in ‘acid crash’. Despite both MES and CaCO3 
being adequate buffers, CaCO3 appears to have inhibited cell growth with OD600 only 
reaching around 2.5 compared to around 6 in the MES buffered cultures Figure 3.3A. 
Despite the observed inhibition of growth in the CaCO3 fermentations, the OD600 of the 
CaCO3 fermentations is not representative of the actual culture turbidity or health. This is a 
result of CaCO3 inability to fully dissolve into solution at the concentrations required for 
effective pH buffering. This causes large visible particles of CaCO3 in solution, whereas 
MES is able to fully dissolves, is colourless and does not absorb visible light. Due to this, it 
becomes almost impossible to be able to accurately blank CaCO3 buffered solutions at 
OD600 and results in it being less effective at accurately measuring the OD600 during 
fermentation. This inaccuracy is shown by the larger error bars and the flatter growth curve 
























Figure 3.3 Fermentation analysis using CaCO3 and MES pH buffering systems. A). OD600 and B). 
pH of C. saccharoperbutylacetonicum N1-4(HMT) grown in YETM with 40g L -1 glucose with either MES 
(closed squares) or CaCO3 (closed circles) as a buffering agent during fermentation.  
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3.3.3 Assessment of analytical techniques for measurement of acids, solvents and 
sugars. 
 
Herein we assess the methodology used for the measurement of the end products of 
fermentation (i.e. acids and solvents) and establish methodology to measure the depletion 
in sugar concentrations.  For the measurement of acids and solvents, Gas Chromatography 
Mass Spectrometry (GCMS) was used. To measure sugar concentrations in the 
fermentation mix, HPLC was used for sugar mixtures as well as single sugar fermentations. 
In addition to this, glucose concentrations were measured using HPLC (with refractometry 
detection) and were compared to measurements made with a hand-held glucometer similar 
to those used by diabetic patients. 
 
3.3.3.1 Solvent and acid quantitation 
 
As described above, GCMS was used as the methodology of choice for the detection and 
quantification of acids and solvents during fermentation. GCMS chromatographs in Figure 
3.4 show the retention time of each of the compounds that are being measured during ABE 
fermentation, acetic acid (11.42 min), butanoic acid (12.9), acetone (2.8 min), butanol (8.5 
min) and ethanol (5.4 min). Figure 3.4 also shows show the solventogenic shift that occurs 
during fermentation, with peak acetic acid and butanoic acid concentrations occurring 
between 6 -12 h, followed by their consumption as the cells switch to solventogenesis from 
12 – 24 h. To enable quantification of ABE fermentation products, standard curves were 







































Figure 3.4. GCMS Chromatographs from C. saccharoperbutylacetonicum N1-4(HMT) YETM 40 g L 
-1 batch fermentation for the identification of the acids (acetic acid and butanoic acid) and solvents 
(acetone and butanol). 2ml of cell culture taken from cells growing in a batch fermentation and separated 
by centrifugation. Sample supernatants were taken and run on the GCMS following protocol in section 
2.8.4 
Retention time (Min) 
Fermentation time (h) 
































Figure 3.5 GCMS standard curves. Solvents 
were diluted in H2O to corresponding g / L 
concentration and ran on the GCMS following the 
protocol in Section 2.8.4. A). Acetic acid, B.) 




3.3.3.2 Optimisation of sugar quantification 
 
Alongside the ability to be quantify acids and solvents during fermentation, it is important to 
identify and quantify sugars due to the complex nature of different feedstocks and the 
changes in rates of feed and carbon utilisation that occurs. Sugars quantification was 
performed via High-pressure liquid chromatography (HPLC). While very sensitive, HPLC 
can be time consuming and expensive, especially for fed batch or continuous fermentation 
experiments where the concentrations of sugars are monitored regularly. To overcome this, 
the use of a glucometer, similar to those used by those by diabetics, was employed as a 
way of quickly and easily measuring glucose concentrations during fermentations. To test 
the accuracy of the glucometer, a fed batch fermentation was carried out. Following a 16 h 
batch overnight, the glucose concentrations were maintained below 20 g L -1 for the 
remainder of the fermentation. During this time, the glucometer was used to measure 
glucose concentrations from each sample. This dictated the feed rate that maintained the 
glucose concentrations at the desired level. At the same time, samples were taken for 
subsequent analysis via HPLC to allow for comparison of the two methods. The data reveal 
that although the glucometer struggles at higher sugar concentrations (>25 gL-1) it is a 
relatively accurate method for measuring glucose concentrations when compared to the 











Figure 3.6 Glucose concentrations during fed batch fermentation comparing the 
ability of the Glucometer vs HPLC analysis. C. saccharoperbutylacetonicum N1-
4(HMT) was grown in YETM 50g L-1 glucose as a starting sugar concentration. Feed 
rate was kept the same at throughout. 300 g L -1 glucose was consumed for the duration 
of the fermentation. 2 mL cell samples were taken during fermentation, separated via 
centrifugation and the supernatant separated and used to measure glucose 
concentrations using both the Glucometer and HPLC.  
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3.3.4 Implementation of new fermentation approaches for integrated analysis of ABE 
fermentation 
 
To initially test the fermentation setup a batch fermentation was carried out. For this, wild 
type C. saccharoperbutylacetonicum N1-4(HMT) grown according to the seeding process 
described in section 2.4.4 into a final culture volume of 500 mL of YETM 40g L -1 glucose 
with 0.1 M MES as a buffering agent. The batch fermentation was carried out at 32 oC for 
48 h. Anaerobic conditions were established by purging with filtered (0.2 µm pore size) N2 
for 30 min per vessel prior to inoculation and then 10 min following inoculation. The batch 
fermentations were run in triplicate and set up as illustrated by the schematics in Figure 
3.1A. 
 
The final OD600 measured was 7.2 ± 0.2, the lowest pH value reached was 5.09 ± 0.03, and 
the lowest redox value reached was -298 ± 9 mV vs. NHE (Figure 3.9A). Glucose 
consumption was measured using HPLC (Figure 3.9B). This showed that the glucose 
concentration diminished from the initial 40 gL -1 to 1.3 ± 1.96 g L-1. 
 
Peak concentrations of acetic acid and butanoic acid at 12h (Figure 3.9C) were 0.203 ± 
0.03 gL-1 and 0.17 ± 0.005 gL-1, respectively. Acid concentrations were fully depleted by 30 
h and solvent production started at 12 h. Solvent concentrations were at maximum levels 
at 45 h, with a peak acetone concentration of 4.9 ± 0.48 g L -1 and a peak butanol 
concentration of 13.4 ± 0.8 g L -1.  
 
To conclude, it has been demonstrated above that it is possible to design and construct a 
fermentation system that has similar functionality to commercial units at a fraction of the 
cost. In addition to this, a system for detection and quantification of acids, solvents and 





  Figure 3.9 Overview of growth, acids and solvents of a C. saccharoperbutylacetonicum N1-
4(HMT) batch fermentation in the shepherd fermentation system. A). Output obtained for OD600, 
pH and Redox (mV vs NHE); B). Glucose consumption during fermentation measured using HPLC; 
C). Concentrations of Acetic acid (closed circles), Acetone (open circles), butanoic acid (Closed 











3.7.1 General Discussion 
 
As the revival of ABE fermentation in Clostridium continues to grow in the wake of 
renewable energy demands, reducing cost barriers at the point of access will be important 
to promote research in this area, especially in lower income countries. As the cost of 
specialist fermentation technology can be high (Table 3.1.), the current project aimed to 
create a cost-effective alternative that uses affordable parts in conjunction with equipment 
available in most labs (e.g. spectrophotometer for OD600 readings).  
 
The system designed here is versatile, easy to set up and run, and shares many of the 
same functionality as current commercial models such as, pH and redox measurements, 
along with the ability to be set up for batch/fed batch or continuous processes (Figure 3.1). 
In addition to this, the techniques for measuring compounds of interest such as acids, 
solvents and sugar consumption have been established (Figure 3.4 & Figure 3.5 & Figure 
3.6). 
 
3.7.2 Dissolved oxygen control and control 
 
The functional repertoire of the current fermentation system could be expanded by 
introducing in-line dissolved oxygen (DO) measurements, similar to commercial systems 
from Electrolabs, Eppendorf or Bionet. While this is of limited value for anaerobic cultures 
other than to ensure that the media is indeed anaerobic, DO measurements may be 
useful for other fermentation applications such as the production of protein therapeutics in 
E. coli. 
 
To measure DO in a system, a DO probe is required and typically, this is what commercial 
systems provide. Recently however (Sadie R. Bartholomew, 2006) have developed a cost-
effective CHO K-1 cell bioreactor. The main goal set out by (Sadie R. Bartholomew, 2006) 
was to establish a method that could be used to introduce oxygen into the bioreactors, as 
well as measure the concentration of DO during growth. Oxygen was introduced into a 
bioreactor via the catalytic breakdown of hydrogen peroxide with manganese oxide. 
Alongside this, the Winkler dissolved oxygen assay (Winkler, 1888) was adapted to fit a 
microscale volume which when compared to DO reading from a DO probe gave a linear 
relationship of r2 =0.9995. 
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In the future, it would be possible to introduce the methods described by (Sadie R. 
Bartholomew, 2006) in the system designed in this chapter allowing for introduction of 
oxygen and measurement of dissolved oxygen in the system in a cost-effective manner.   
 
3.7.3 pH control and acid crash 
 
pH control of ABE fermentation is important for maximising solvent yields. Acid crash and 
the mechanisms involved have been investigated previously (Martin et al. 1983; Wang et 
al. 2011; Zverlov et al. 2006)(Yang et al., 2013). Acid crash, as the name suggests, is 
characterised by a dramatic decrease in pH leading to the cessation of glucose uptake and 
very little solvent production. Over-production of un-assonated acids (i.e acetic and butyric 
acid) from acidogensis at a concentration of 57-60 mmol/L are thought to be the main cause 
of acid crash (Maddox et al., 2000). Acid production, in particular butyric acid, is key in the 
shift from acidogensis into solventogenesis. It has previously been reported that a minimum 
concentration of 1.5 g L -1 butyric acid results in the shift into solventogenesis (Frederic 
Monot , Jean-Marc Engasser, 1984). However, it is not fully understood at which pH acid 
crash will occur and in addition to this George and Chen 1983 reported that acidic conditions 
are not required for the solventogenesis to occur.   
 
The system designed in this chapter has the ability to control the pH via the addition of 
buffering compounds, although it is not able to buffer pH automatically via titration of acids 
or alkalis. In our system, bolus additions of CaCO3 and MES were tested as pH buffering 
solutions. CaCO3 as a buffer during fermentations has previously been extensively studied 
(Tsai et al., 2014)(Ai et al., 2014)(Yang et al., 2013)(Wang et al., 2019), and has been 
shown to extend cell growth time, alleviate inhibitory effects of acid production as well as 
toxicity of butanol (Kanouni et al., 1998), leading to higher overall yields of solvents. MES 
buffer was first described in Good et al. 1966 as part of an investigation into hydrogen ion 
buffers for biological research with various favourable properties. 
 
As shown in Figure 3.3, CaCO3 provided a good level of pH buffering acids, preventing the 
pH of the culture to drop below pH 5 similar results were achieved by MES. The accuracy 
of OD600 measurements with CaCO3 was much lower than with MES as shown by the larger 
error bars in Figure 3.3A. The higher error bars and the reduction in the actual measurable 
OD600 of the samples buffered with CaCO3, is not believed to be a result of the CaCO3 itself. 
Unlike MES, the solubility of CaCO3 is only 0.013 g L -1 compared to MES, which has been 
documented at upwards of 0.5 M or 97 g L -1 due to the lack of solubility of CaCO3 when 
measurements of OD600 the concentration of dissolved CaCO3 in the sample is unknown 
making readings inaccurate and unrepresentative of the real cell density due to background 
absorption by undissolved CaCO3.  
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Although CaCO3 and MES have been chosen for use herein, ammonium acetate, sodium 
bicarbonate, acetate buffer, sodium acetate and citrate buffer (Yang et al., 2013) (Tsai et 
al., 2014) (Xue et al., 2016)  have all been used to varying degrees of success. CaCO3 was 
used here as it cheap, effective and buffering and has been extensity studied.  A recent 
review of the functionality of the Goods buffers (Ferguson et al., 1980) has leads to an 
understanding and selection of “better” buffers, providing schematics and insight into the 
best pH ranges for the non-complexing tertiary amine buffer compounds (Kandegedara and 
Rorabacher, 1999), this review reveals that MES has a more preferential pka values related 
to acidogenesis pH levels compared to other good buffers throughout temperature ranging 
from 15-45 oC, for this reason MES was used as the buffer of choice herein.   
 
3.7.4 Concluding remarks 
 
A cost-effective fermentation system was designed and constructed that incorporates many 
of the same functionalities as commercially available systems, and reliable approaches for 
pH modulation and metabolite analysis have also been established. This work will be 
important for researchers requiring reproducible and industrially relevant clostridial culture 
techniques, and indeed for researchers working on microbial biofuel formation with other 
organisms such as yeast and algae. 
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Chapter 4  
 
Deletion of the gapN gene from C. 
saccharoperbutylacetonicum N1-4(HMT) 
using CLEAVE™ and subsequent evaluation 
∆gapN C. saccharoperbutylacetonicum N1-





4.1 Summary  
 
Despite the recent revival in research into Clostridium spp. and the growing interest into the 
industrial capabilities of solventogenic strains of Clostridium, the development of tools for 
genetic engineering of these strains has lagged behind those of Gram-negative species 
such as E. coli. In this chapter, we exploit the new CLEAVEÔ methodology (Jenkinson et 
al., 2015) a CRIPSR/Cas tool developed by Green biologics Ltd, to delete the gapN gene 
from the chromosome of C. saccharoperbutylacetonicum N1-4(HMT). Following successful 
deletion of gapN, whole genome sequencing (WGS) was carried out using illumina MiSeq 
technology on the wild type and gapN strains to screen for additional unwanted mutations 
that may be introduced by CLEAVEÔ. The WGS from the ∆gapN C. 
saccharoperbutylacetonicum N1-4(HMT) shows no undesired or unwanted mutations as a 






Clustered Regulatory Interspaced Palindromic Repeats (CRISPR) alongside their 
associated Cas proteins are part of the adaptive immune system within prokaryotes (Figure 
1.5). In recent years as the molecular biology toolkit available to Clostridium has grown, so 
has the adaption and use of CRISPR/Cas systems within a variety of Clostridium spp. 
(Bruder et al., 2016; Huang et al., 2016; Nagaraju et al., 2016; Wang et al., 2017a; Wasels 
et al., 2017). Typically, CRISPR/Cas systems used in Clostridium spp. involve screening 
against those strains that have successfully undergone a homologous recombination (HR) 
event. Those that have undergone a successful HR event are typically those that survive 
as the CRISPR/Cas machinery will be targeting wild type strains that have not undergone 
HR. The technology used herein was developed by Green Biologics Ltd. as their proprietary 
CRISPR/Cas system. CLEAVEÔ makes use of the endogenous CRISPR-Cas systems of 
the bacteria and is not limited to C. saccharoperbutylacetonicum N1-4(HMT), it has 
previously been shown to successfully generate strains carrying desired SNPs as well as 
those with deletions and insertions (Atmadjaja et al., 2019), although detailed WGS 
analyses have not previously been performed on the engineered strains to screen for 
unwanted mutations. CLEAVEÔ has been utilised herein for the deletion of the gapN gene 
that for encodes the glyceraldehyde-3-phosphate dehydrogenase GapN from the genome 
of C. saccharoperbutylacetonicum N1-4(HMT), an industrially relevant butanol hyper-
producing Clostridium strain. 
 
The work carried out in this chapter focuses on GapN, a cytosolic non-phosphorylating 
NADP-dependant GAPDH that catalyses the irreversible oxidation of glyceraldehye-3-
phosphate (G3P) to 3-phospholycerate (Figure 4.1). However, three classes of 
glyceraldehyde-3-phosphate dehydrogenases (GAPDH) that are known to be involved in 
the central carbon metabolism pathway (Fothergill-Gilmore and Michels, 1993) With the 
other two being; (i) A NAD-dependant glycolytic enzyme found in the cytoplasm of all 
organisms, which plays a key role in the Embden-Meyerhoff pathway in glucose as well as 
gluconeogenesis; (ii) An NADPH-dependant GAPDH that is a key component of the 
reductive pentose-phosphate cycle (Iddar et al., 2002).  
 
Originally discovered in photosynthetic eukaryotes (Mateos and Serrano, 1992), GapN has 
gone on to be confirmed in Streptococcus mutans and S. salivarius (Boyd et al., 1995). 
Recombinant GapN from Streptococcus mutans has been expressed in Corynebacterium 
glutamicum as a route for NADPH generation to facilitate L–Lysine production (Takeno et 
al., 2010). Additionally, recombinant GapN from C. acetobutylicum has been expressed in 




Despite developing complex metabolic networks for energy generation (Demmer et al., 
2015), anaerobic bacteria lack the ability to generate ATP via oxidative respiration. In a 
sense this can be seen as a limiting factor in energy generation as generally having a larger 
pool of ATP is seen as a positive for the cells. As described above, GapN forms part of the 
glyceraldehyde-3-phophate oxidation pathway (Figure 4.1). Previous flux analysis in in C. 
acetobutylicum (Minyeong Yoo, Gwenaelle Bestel-Corre, Christian Croux, Antoine Riviere, 
Isabelle Meynial-Salles, 2015) has revealed that GapN is poorly expressed at 0.56 mRNA 
molecules per cell in comparison to 66 mRNA molecules per cell of GAPDH. This poor 
expression leads to only 3500 protein molecules per cell of GapN compared to 190000 
protein molecules per cell of GAPDH. It was predicted that GapN would only be responsible 
for around 5% of flux through the glyceraldehyde-3-phosphate oxidation pathway. With the 
knowledge of predicted low flux and alongside the poor expression data, the gapN gene in 
C. saccharoperbutylacetonicum N1-4(HMT) was targeted for the creation of a ∆gapN C. 
saccharoperbutylacetonicum N1-4(HMT) as a way of recovering any ATP generation within 
the cell that may be as a result of the flux lost through GapN in the glyceraldehyde-3-
phophate oxidation pathway (Figure 4.1). In addition to this, recombinant GapN expression 
has been used a method of NADPH generation in other bacteria, deletion of GapN may 
alter the NADH/NADPH ratio within C. saccharoperbutylacetonicum N1-4(HMT) (Centeno-
Leija et al., 2014). 
 
Following deletion of the gapN gene from C. saccharoperbutylacetonicum N1-4(HMT) 
whole genome sequencing (WGS) was carried out to assess the precision of CLEAVEÔ 
























































Figure 4.1 The pathways involved in conversion of glyceraldehyde 3-phosphate to 3–
phosphoglyceric acid in C. saccharoperbutylacetonicum N1-4(HMT). Also known as the 





4.3.1 Deletion of gapN in C. saccharoperbutylacetonicum N1-4(HMT) using CLEAVEÔ  
 
Deletion of gapN was carried out using the proprietary CRISPR/Cas technology CLEAVE™ 
developed by Green Biologics limited (Jenkinson et al., 2015). The CLEAVE™ process 
consistent of three main steps. (i) Homologous recombination vector generation and 
transformation. The homologous recombination vector consists of a substitution cassette, 
that contains homology arms that are able to replace all of or part of the intended site of 
mutation. The homologous recombination vector does not contain any CRISPR/PAM 
protospacer that is recognisable by the crRNA of the CRISPR/Cas system in the cells. (ii) 
Following transformation with the recombination vector, the bacteria population undergo 
several rounds of sub culturing. The sub culturing stage of CLEAVE™ is intended to 
encourage the bacterial population now transformed with the recombination vector to 
undergo a double recombination event at the intended site, replacing the wild type genome 
with that in the recombination vector; stopping the now replaced DNA from being recognised 
by the crRNA of CRISPR/Cas. (ii) Finally, following sub-culturing, the cells are finally 
transformed with the Killing vector. The killing vector is capable of producing crRNA which 
targets the PAM protospacer site within the intended region of mutation where the double 
recombination event has taken place. The crRNA within the killing vector will only be able 
to recognise the PAM/protospacer within cells that have been unable to undergo the double 
recombination event and still contain the wild type DNA, resulting in killing of those cells 
that have not undergone double recombination. Following transformation with the killing 
vector, cells are plated, colonies are selected and screened for desired mutations.  
 
4.3.1.1 Creation of the Homologous recombination vector and sub-cloning 
 
The first step in the CLEAVE™ process is the design and construction of the homologous 
recombination (HR) vector and the gapN deletion cassette. To construct the gapN deletion 
cassette, colony PCR of C. saccharoperbutylacetonicum N1-4(HMT) was carried out to 
amplify 2 x 1.5 kb regions upstream and downstream of gapN. The 1.5 kb fragments 
upstream of gapN was designed to contain a 25 bp 3' region that was complementary to 
the 5' end of the downstream fragment (Figure 4.2). In doing this, it was possible to generate 





































Following successful PCR reactions, fragment isolation and Sanger sequencing to confirm 
the correct sequence of the deletion cassette, it was successfully blunt cloned into the HR 
vector. This can be seen in Figure 4.3A whereby successful cloning would remove the StuI 
restriction site within the plasmid, and when digested with NdeI + HindIII two fragments 
would be visible, one around 3kB and 250bp. The new HR gapN deletion vector was first 
transformed into E. coli.  The HR vector pMTL82154 is a linage of the pMTL80000 shuttle 
vector system first described by (Heap et al., 2007) The HR vector is formed of the following 
components a pBP1 Gram-positive replicon, catP antibiotic maker, ColE1 +tra Gram-
negative replicon and a catP reporter gene Figure 4.3B. After successful transformation into 
E. coli the HR_gapN_del vector isolated and was transformed into C. 
saccharoperbutylacetonicum N1-4(HMT).  
  
Figure 4.2 Diagrammatic representation of the PCR reaction used to create the deletion cassette insert 
for the Homologous Recombination vector. 1). Amplification of 1 kb fragment 3‘ of the gapN gene using 
primers HR1 and HR2 with HR2 containing complementary to the HR3 primer. 1 kB fragment 5’ of gapN 
amplified using HR3 and HR4 with HR3 having complementary sequence to HR2. 2). HR1 and HR4 used with 
two newly PCR amplified 1 kb fragments with overhangs to fuse both fragments together. 3). Assembled 










































Figure 4.3 - Cloning of the homologous recombination vector for deletion of gapN. A). 1% 
agarose gel showing: lane 1 – Undigested miniprepred pMTL82154 + homologous recombination 
(HR) fragment. Lane 2 – Minipreped pMTL82154 + HR fragment digested with StuI. Lane 3 – Double 
digest with HindIII and NdeI of pMTL82154 + HR fragment. Lane 4 – 1kB Gene ladder. B).  Vector 




























1.3.1.2 Design and construction of Killing Vector 
 
Like the HR vector, the killing vector (also known as the CRISPR/Cas targeting vector) is 
derived from the pMTL8000 shuttle vector system (Heap et al., 2007). The killing vector is 
a modified version of pMTL83251. Traditionally pMTL83251 consists of Gram-positive 
replicon pCB102, ermB antibiotic marker, ColE1 + tra Gram-negative replicon and a multiple 
cloning site (MCS). Pre-Engineered into the MCS of pMTL83251 is the native leader 
sequence (LDR), a 181 bp sequence that is found downstream of the Cas2 machinery in 
C. saccharoperbutylacetonicum N1-4(HMT). With the leader sequence pre-engineered into 
pMTL83251 it allows for the construction of CRISPR/Cas clusters on the plasmid that 
replicate how they are seen natively within the cells. The CRISPR/Cas targeting system 
seen in C. saccharoperbutylacetonicum N1-4(HMT) is formed of DR_Target-specific-
spacer_DR clusters downstream of the Cas2.  For the successful deletion of gapN a 
DR_gapN-spacer_DR cluster was created insilico (Figure 4.4), synthesised and 
successfully cloned into pMTL83125 (Figure 4.5). The ~50 bp gapN spacer sequence that 
was used in the DR_gapN_spacer_DR was found adjacent to a 5’ – CCX sequence within 




Figure 4.4 Overview of the killing vector targeting cassette for endogenous CRISPR-




Figure 4.5 PCR screening for successful ligation of DR_gapN_DR spacer sequence into 
the pMTL83125 vector. (A) 2% agarose gel showing PCR products from E. coli colonies 
screened with M13 primers after ligation of killing vector fragment into pMTL83251 Lane 5 
shows successful ligation. (B) Diagram of expected final killing vector construct after successful 
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4.3.1.3 Confirmation of gapN deletion from the genome of C. 
saccharoperbutylacetonicum N1-4(HMT) 
 
Following successful transformation of the killing vector a total of 144 colonies post 
transformation from undiluted cultures and 10 colonies from 1/10 culture dilutions were 
obtained. 15 colonies were screened in total, from this initial screen, a large proportion of 
screened colonies appeared successful (Appendix I). From these initially screened colonies 
one colony was taken, re-screened and sent for sequencing (Figure 4.6). For the CPCR 
HR1 and HR4 primers were used. These primers anneal upstream and downstream of 
gapN, were used in the construction of the HR vector and following amplification resulted 
in a fragment that was 1256 bp in length compared to the wild type at around 3 kB containing 
the gene gapN. Successful colonies were sent for Sanger sequencing to confirm successful 

















Figure 4.6 Colony PCR screening of C. saccharoperbutylacetonicum N1-4(HMT) ∆gapN 
mutants. 1% agarose gel was used to resolve PCR products. Lane 1: GeneRuler 1kB ladder 
(Thermos Fisher Scientific). Lane 2: Negative control of PCR without template DNA but still 
containing primers and Phusion. Lane 3: Positive control PCR of wild type strain. Lane 4: 16S 
PCR to ensure that cell lysis was successful for Lane 3 PCR.  Lane 5: PCR confirming deletion 
of gapN in the genome. Fragment size with gapN deletion is expected to be around 1256bp. 
Lane 6: 16S PCR confirming cell lysis in Lane 5.   
 








































4.4 Whole genome sequencing and comparison of ∆gapN and wild type C. 
saccharoperbutylacetonicum N1-4(HMT). 
 
To evaluate the effectiveness and specificity of CLEAVEÔ, whole genome sequencing via 
Illumina MiSeq was carried out on both wild type and ∆gapN C. 
saccharoperbutylacetonicum N1-4(HMT). It was deemed necessary to be directly involved 
in the sequencing process, rather than commercial outsourcing, to gain an in-depth 
understanding of the process to enable a thorough quality control analysis of the data 
generated. An overview of the pipeline and sequence evaluation techniques used are 
shown in Figure 4.7. A genome library for both the wild type strain and the ∆gapN were 
prepared using the Nextera® XT DNA Library Prep Kit, which is optimized for small 
genomes. This kit uses a transposome complex that simultaneously fragments genomic 
DNA and inserts adapter sequences. Following on fragmentation and adaptor insertion, a 
PCR step uses the adapter to amplify the DNA fragments and add specific index sequences 
to each genomic DNA sample, thus allowing sequencing of pooled libraries (this process is 
often termed ‘barcoding’). Once the libraries for the wild type and ∆gapN strains were 






Figure 4.7 Diagram detailing the process of genome evaluation following illumina Miseq of the 
wild type and ∆gapN C. saccharoperbutylacetonicum N1-4(HMT). 
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4.4.1 Genomic read mapping of Illumina reads 
 
The resulting short paired-end reads were assessed using FastQC before and after 
trimming of the reads using Trimmomatic (Bolger et al., 2014). Trimmomatic removes 
adaptor sequences inserted during library preparation, as well as low quality reads and 
bases from each dataset. The final trimmed reads from the wild type and the ∆gapN strain 
were mapped to the reference C. saccharoperbutylacetonicum N1-4(HMT) genome 
obtained from Genbank (CP004121.1). The mapping was carried out using BWA and 
Samtools (Li, 2013), and then Qulimap (García-Alcalde et al., 2012) was used to assess 
the quality of genome mapping of both strains (Table 4.1). Qualimap revealed that the main 
difference between the assemblies is that the coverage depth in the wild type strain is much 
lower than for the ∆gapN strain, meaning that during the process of sequencing the number 
of unique reads given to each nucleotide in the reconstruction process is much lower than 
in the wild type strain than in the ∆gapN. A coverage depth of 68.59 ± 33.2 is seen in the 
∆gapN strain and 18.8 ± 11.3 is seen the wild type C. saccharoperbutylacetonicum N1-
4(HMT), this was thought to be a result of poorer quality starting material from the genomic 
DNA extraction process . Although coverage varied, 97.12 % of the total 596,655 reads for 
the wild type strain were mapped and 95.21% of the total 2,093,890 from the ∆gapN were 
successfully mapped to the reference genome obtained from Genebank (CP004121.1). The 
full Qualimap reports for wild type C. saccharoperbutylacetonicum N1-4(HMT) can be found 
in the Appendix E1 and appendix E2 for both the ∆gapN strain and wild type strain.  
 
Table 4.1 Qualimap results of C. saccharoperbutylacetonicum N1-4(HMT) ∆gapN and 
Wild type following read mapping via bwa to the reference C. 
saccharoperbutylacetonicum N1-4(HMT) obtained from Gene bank (CP004121.1)  
 C. saccharoperbutylacetonicum N1-4(HMT) 
Strain  
Characteristic  ∆gapN Wild Type  
Reference size (bp) 6,530,257 6,530,257 
Number of reads  2,093,890 596,655 
Mapped reads 1,993,694 / 95.21% 579,484 / 97.12% 
Supplementary 
alignments 1,509 / 0.07% 247 / 0.04% 
Unmapped reads 100,196 / 4.79% 17,171 / 2.88% 
Read min/max/mean 
length (bp) 30 / 251 / 224.9 30 / 251 / 212.68 
Clipped reads 21,456 / 1.02% 4,726 / 0.79% 
Mapping Quality  59.11 59.30 




4.4.2 Sequence variant analysis and SNP identification  
 
Once mapped, the illumina reads for the wild type and ∆gapN strain were analysed for 
variations between both sets of reads and the reference genome. Snippy 
(https://github.com/tseemann/snippy). is a software that finds SNPs between a reference 
and query next generation sequences (NGS). An overview of the variations found in the 
wild type and ∆gapN strain when compared to the reference genome for C. 
saccharoperbutylacetonicum N1-4(HMT) Genbank (CP004121.1) can be found in Table 4.2. 
Snippy reveals a total of 165 SNPs in the wild type NGS and 17 in the ∆gapN NGS, the 
complete list of all identified SNPs in both strains can be found in Appendix G.  
 
Table 4.2 Breakdown of the total number of mutations identified in the wild type and ∆gapN 
strains compared to reference C. saccharoperbutylacetonicum N1-4(HMT) genome obtained 
from Gene bank (CP004121.1) by Snippy 
 C. saccharoperbutylacetonicum N1-4(HMT) Strain 
 Wild Type ∆gapN 
Mutation type:    
Complex  9 1 
Deletion 9 4 
Insertion 3 2 
SNP 142 10 
Total Variants   165 17 
 
The SNP’s identified by Snippy in the ∆gapN WGS were manually investigated using the 
Integrated genome viewer (IGV) (Robinson et al., 2011) alongside the wild type WGS 
mapping to further investigate withier or not the identified SNP’s are a result of sequencing 
error. The SNP’s predicted SNPs in the ∆gapN WGS occur within the following genes; ybdl 
(a predicted methionine transferase), rocR_1 (predicted arginine utilization regulatory 
protein), rsgl_2 (a predicted anti-sigma-I factor), fdtB_2 (a predicted dTDP-3-amino-3,6-
dideoxy-alpha-D-galactopyranose transaminase) and a hypothetical coding region.  
 
Manual inspection of the SNP’s identified in the ∆gapN WGS with the Wild type WGS in 
IGV (Appendix G1-7) show that all of the SNP’s identified by Snippy (Appendix H) are 
also present in the WGS for the Wild type strain. This suggests that the Snippy predicted 
SNPs may not be genuine SNPs in the ∆gapN strain and they may be due to an error in 
sequencing or processing of the sequencing data and when compared to the published 




4.4.3 Whole genome annotation of Wild type and ∆gapN illumina reads 
 
Once each of the genomes had been assembled both were annotated using Prokka 
(Seemann, 2014), a prokaryotic annotation software. Following annotation of the wild type 
C. saccharoperbutylacetonicum N1-4(HMT) and the ∆gapN NGS using Prokka, both 
annotations were compared to each other to gain a list of genes that are present or absent 
between the two assemblies. This analysis was carried out by Roary (Page et al., 2015). 
Typically used for the identification of large pan genomes in bacteria, Roary is able to 
compare two assembled and output a list of genes that are present and absent between 
both the wild type and ∆gapN assemblies. Roary identified a total of 5827 genes with a 
similarity of 97% (5659 genes) between the wild type and ∆gapN. Of the total 5827 genes 
130 (2.2%) were uniquely identified in the ∆gapN strain and only 38 genes (0.65%) were 
unique to the wild type annotation and not ∆gapN. Complete Gene presence and absence 
can be found in Appendix I. Visualisation of the annotated genomes post Prokka was 
carried out using the BLAST atlas setting of the Gview server. (https://server.gview.ca/) 








Figure 4.8 Whole genome comparison of the reference C. saccharoperbutylacetonicum N1-4(HMT) 
to genome assembly of the ∆gapN and wild type strains illumina sequenced strains. Inner ring 
(black) relates to the complete genome sequence of C. saccharoperbutylacetonicum N1-4(HMT), Fasta 
file for whole genome obtained from gene bank (CP004121.1). Purple ring related to the GC screw in the 
reference genome. Orange ring, genome annotation assembly from reference 
saccharoperbutylacetonicum N1-4(HMT), GBK for annotation obtained from gene bank (CP004121.1). 
Blue ring – Prokka assembly of illumina sequenced and Prokka annotated wild type C. 
saccharoperbutylacetonicum N1-4(HMT). Red ring – Prokka assembly of illumina sequenced and Prokka 




4.6.1 CLEAVE™ results in successful deletion of ∆gapN and analysis reveals that it 
is accurate 
 
Genetic manipulation of Clostridium spp. has lagged behind that of other well established 
industrially relevant organisms such as E. coli and S. cerevisiae. Prior to 2007 only a handful 
of targeted mutant strains had been established in Clostridium spp. (Clark et al., 1989; 
Harris et al., 2000; Mermelstein et al., 1993) with almost all of them being constructed by 
the process of either single or double recombination which themselves brought their own 
issues. In single recombination events a plasmid serves as an insertional mutagen, this is 
typically very unstable (Heap et al., 2012). In double recombination events the wild type 
allele is exchanged with the desired mutant allele. Double cross over events however were 
typically hard to screen for as the negative selection markers used in other more established 
strains were not yet developed in Clostridium spp., until the advent of Group II mutagenesis 
system ClosTron (Heap et al., 2007) (Figure 1.4A). Post 2007 with the advent of available 
CRISPR/Cas and CRISPR interference (CRISPRi) technology the scope and flexibility of 
genetic tools in Clostridium has been quickly catching up to that of other industrial strains 
(Atmadjaja et al., 2019; Jenkinson et al., 2015; Joseph et al., 2018; Nagaraju et al., 2016; 
Wang et al., 2016; Woolston et al., 2018)  
 
CLEAVE is a newly developed technology for CRISPR/Cas genome editing within 
Clostridium spp. because of this the literature around this technology is limited. Atmadjaja 
et al., (2019) have published work that details the discovery and deisgn of the CLEAVE™ 
including the discovery of the CRISPR/Cas features within C. saccharoperbutylacetonicum 
N1-4(HMT), including the idenfitifcation of C. saccharoperbutylacetonicum N1-4(HMT) PAM 
sites. In additon to documenting the developemnt of the CLEAVE™ the work also 
demonstrates the flexibility of CLEAVE for the creation of new strains containing SNPs, 
Deletions and Intigrations. In the work, intigraiton of varying sized lambda phage DNA (1,3,5 
kb). into a site 4.8 kb downstream of the pyrE gene was tested. For the intigration of 1 kb 
fragemtents a success rate of 60% was achived, for 3 kb fragments a success rate of 53 % 
was achived and for 5 kb fragments a success rate of 35% was achived. It was noted that 
the decrease in intigration of larger fragments might be due to the instability of larger 
plasmids generated when intigrating larger Lambda DNA seqeuences.  
 
Both deletion and SNP generation were attempted in the gene spo0A. For the SNP, a single 
nucleotide in the 782 position was modified in an attempted to cause the change I261T in 
spo0A, in addition a silent mutation was incorporated 180 bp upstream of the SNP to knock 
out the PAM site. Validation of the targeting spc vector as positive control resulting in a 
>99.5% efficiency in killing of wild type strains. However, when transformed with targeting 
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vector for the SNP, only 5 colonies were obtained with subsequently only 1 colony of the 5 
being positive for the desired mutation.  
 
Finally, deletion of the gene Spo0A was achieved using CLEAVE. As with the work in this 
thesis, deletion of a single gene within the genome of C. saccharoperbutylacetonicum N1-
4(HMT) was achived. Similar to the results here for the deletion of gapN, a 100% success 
rate was achieved when attempting a deletion of a single gene within the genome. 100% of 
the 30 colonies tested by Atmadjaja et al., (2019) being postive for the deletion.  
 
4.6.2 NGS results of ∆gapN C. saccharoperbutylacetonicum N1-4(HMT) 
NGS analysis of ∆gapN by illumina MiSeq provided a good depth of coverage (x68 ± 33) 
that resulted in 95% coverage of mapped reads. Alongside the ∆gapN strain, illumina Miseq 
was carried out for the wild type C. saccharoperbutylacetonicum N1-4(HMT) as a control 
sequence against for analysis post sequencing. Coverage in the wild type was not as good 
at a depth x18 ± 11 however 97% of the reads were able to be mapped. Despite Snippy 
detecting 17 SNP’s throughout the NGS of ∆gapN the SNP’s discovered were also present 
and identical in the NGS from the wild type C. saccharoperbutylacetonicum N1-4(HMT) 
(Appendix H1-7), suggesting that these mutations may not be as a result of the CLEAVE 
process, but errors in the sequencing and analysis process. Genome annotation and 
subsequent comparison of annotations reveal a high similarity of 97% between both strains. 
Of the 130 genes identified to be present in only the ∆gapN annotation and not in the wild 
type, the majority were hypothetical coding regions of unknown function. GapN was 
identified as part of the 38 unique genes in the wild type NGS and not found in the ∆gapN 
NGS.  
 
Overall, this work has demonstrated the functionality of CLEAVE for the purpose of gene 
deletion with C. saccharoperbutylacetonicum N1-4(HMT) and demonstrates the 






Chapter 5  
 
 
Characterisation of ∆gapN and its potential 





In this chapter the ∆gapN strain created in chapter 4 has been compared to the wild type 
C. saccharoperbutylacetonicum N1-4(HMT) to assess the deletion has on ABE production, 
sugar metabolism, butanol toxicity and ATP concentrations. The main hypotheses driving 
the decision the deletion of gapN is to increase the availably of ATP within the cells. 
Increases in ATP as well as NADH have been shown to be responsible for increased solvent 
production (Meyer and Papoutsakis, 1989). To test is this hypothesis the ∆gapN strain was 
firstly grown on a glucose YETM media in a batch fermentation. By keeping the fermentation 
in a batch set up it provided a clear shift into solventogenesis with the addition to showing 
glucose consumption and any increased to peak butanol concentrations and tolerance. 
Overall the ∆gapN strain exhibited similar growth to the wild type strain in the form of OD600, 
pH, and redox potential. However, the ∆gapN strain produced lower concentrations of acetic 
and butyric acid, throughout and generated elevated concentrations of acetone and butanol 
compared to the wild type C. saccharoperbutylacetonicum N1-4(HMT) until pre-toxic 
concentrations ~ 13 g L-1.  In addition to this the ∆gapN strain exhibited an increased rate 
of glucose consumption during the batch fermentation as well as increased concentrations 
of ATP throughout.  
 
To simulate an industrial feedstock and further assess the impact on sugar metabolism, a 
synthetic C5/C6 hydrolysate mixture was used. Overall deletion of gapN does not appear 
to have any detrimental or enhanced effects of the metabolism of the C5/C6 synthetic sugar 
mix compared to the wild type strain. Consistent with the glucose only batch fermentations 
there was diminished concentrations of acids associated with solvent production (acetic and 
butyric acid) as well as increased concentrations in the production of acetone and butanol 
in ∆gapN strain. Initial batch fermentations showed an increase glucose consumption in the 
∆gapN strain as well as an associated increase in solvent production. To confirm this 
observation a fed batch fermentation was carried out in which glucose consumption of 350 
g L -1 was assessed over a longer 65 h period, with solvent removal via gas stripping to 
ensure toxic concentrations were mitigated. Contrary to the initial batch fermentation, the 
observed rate of sugar consumption during the fed batch experiment was lower in the 
∆gapN strain compared to the wild type. Despite this however, the ∆gapN strain had 
comparable concentrations of solvent production to the wild type strain throughout, 
suggesting that glucose consumption may not be linked to increased solvent production 
seen in the ∆gapN strain as lower consumption in the fed batch does not affect solvent 
production. Finally, increased concentrations of both formic and lactic acid in the ∆gapN 
strain were observed during fermentation. This suggests that there is an accumulation of 
pyruvate within the cell that is being converted to either lactic or formic acid as a means of 




Deletion of gapN has been done in an attempt to recover ATP that would have otherwise 
been lost in the conversion of glyceraldehye-3-phosphate (G3P) to 3-phosphoglycerate via 
flux through GapN in glycolysis. Removal of GapN, forces the cells to use only GAPDH 
(Figure 4.1) instead of using both GAPDH and GapN in the glyceraldehyde-3-phophate 
oxidation pathway of glycolysis. This in turn, will allow for the cell to recover the ATP that is 
generated via the GAPDH side of the glyceraldehyde-3-phophate oxidation pathway that 
otherwise would not be produced in the presence of GapN. As described above, GapN is 
one of three types of GAPDH’s present in the cell and forms part of the glyceraldehyde-3-
phophate oxidation pathway (Figure 4.1). Previous flux analysis in in C. acetobutylicum 
(Minyeong Yoo, Gwenaelle Bestel-Corre, Christian Croux, Antoine Riviere, Isabelle 
Meynial-Salles, 2015) has revealed that GapN is poorly expressed at 0.56 mRNA molecules 
per cell in comparison to 66 mRNA molecules per cell of GAPDH. This poor expression 
leads to only 3500 protein molecules per cell of GapN compared to 190000 protein 
molecules per cell of GAPDH. It was predicted that GapN would only be responsible for 
around 5% of flux through the glyceraldehyde-3-phophate oxidation pathway. This 
previously observed low flux and low levels of regulation within the cell, heavily influenced 
the decision to delete gapN gene from C. saccharoperbutylacetonicum N1-4(HMT). In 
addition to this, recombinant GapN expression has been used a method of NADPH 
generation in other bacteria (Centeno-Leija et al., 2014). ATP is important throughout the 
cell as a key energy carrier and despite developing complex metabolic networks for energy 
generation (Demmer et al., 2015), anaerobic bacteria lack the ability to generate ATP via 
oxidative respiration. This lack of oxidative respiration limits the overall potential for ATP 
production compared to organisms that are able to generate ATP via oxidative respiration. 
Solventogenic Clostridium spp. generation of the majority of their ATP during acidogensis 
(Meyer and Papoutsakis, 1989) with increased ATP and NADH concentrations associated 
with increased solvent production (Meyer and Papoutsakis, 1989). ATP required by the cells 
to undergo reduction processes following glycolysis as well as extrusion of protons by 
means of proton-translocating ATPaes system (Jones and Woods, 1986).  
 
In this chapter we have replicate industrial growth conditions to test the ∆gapN strain 
compared to the wild type. For this batch fermentations were carried out on both C6 only 
(glucose) and a synthetic C5/C6 hydrolysate, as well as fed-batch using C6 over a 
prolonged period of time. It is of note that despite advancements in fermentation techniques 
and solvent recovery processes, the two main limiting factors in the industrial ABE 
fermentation are feedstock (Green, 2011) and the inherent limitations of the bacteria 
themselves, it is hoped that deletion of gapN will aid in elevating the limiting factor of the 
bacteria.  
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5.2 Results  
 
5.2.1 Characterisation of ∆gapN strain during a batch fermentation on glucose YETM 
to assess the impact on ABE production, Butanol toxicity and ATP.  
 
An initial characterisation of the ∆gapN and wild type C. saccharoperbutylacetonicum N1-
4(HMT) strains was performed via batch fermentation in YETM medium containing 40 g L -
1 glucose and supplemented with 0.1 M MES for pH control. Cells were initially grown in the 
seed culture described in Section 2.1.8 before being used for inoculation of the batch 
fermenters that are described in Chapter 3. The experiment was carried out over 45 h. Both 
strains reached similar cell densities, with maximal OD600 values of 7.22 ± 0.22 for the wild 
type and 7.4 ± 0.26 for the ∆gapN strain (Figure 5.1A).  Although fairly similar throughout, 
between the hours 9 and 21 in fermentation, the pH of the fermenter media for the ∆gapN 
strain is less acidic throughout compared to the wild type C. saccharoperbutylacetonicum 
N1-4(HMT) (Figure 5.1B). The redox potential of the growth media for both strains behaved 
in a predictable manner, both dropping to approximately -300 mV vs. NHE in the first few 
hours (Figure 5.1C). Glucose concentrations were also monitored throughout the 
fermentations, and the rate of consumption was greater between 10-20 h compared to the 






























Figure 5.1 Fermentation measurements for ∆gapN (open circles) and wild type (closed circles) 
C. saccharoperbutylacetonicum N1-4(HMT) grown on 40 g L -1 glucose in YETM media using 
shepherd lab fermenters. 0.1 M MES was supplemented as a pH buffering agent. (A) OD600; (B) 













The product of acidogenesis and solventogenesis were then analysed for the ∆gapN and 
wild type strains from the same batch fermentation as described in Figure 5.1.  The ∆gapN 
strain exhibited reduced concentrations of acids throughout the fermentation (Figure 5.2A-
B). In addition, depletion of acid concentrations in the ∆gapN strain also occurred at a faster 
rate in the ∆gapN strain compared to the wild type C. saccharoperbutylacetonicum N1-
4(HMT) (Figure 5.2C-D). The largest observed discrepancies between the strains for acetic 
acid and butyric acid measurements were observed at 15 h: 0.057 g L -1 of butyric acid and 
0.073 g L -1 of acetic acid were measured for the ∆gapN strain, compared to 0.170 g L -1 
of butyric acid and 0.29 g L -1 of acetic acid for the wild type strain. The concentrations of 
acetone and butanol produced by the ∆gapN strain were higher during the first 30 h of the 
fermentation, and largest observed discrepancies between the strains for acetone and 
butanol measurements occurred at 15 h: [acetone] produced by the ∆gapN strain was 3.2 
g L -1 compared with only 1.1 g L -1 in the wild type strain; [butanol] produced by the ∆gapN 
strain was 6.87 g L -1 compared to 3.5 g L -1 in the wild type strain. Peak concentrations of 
butanol in the ∆gapN, however, were similar to those of the wild type cultures at 










Figure 5.2 Acid and solvent profiles for ∆gapN (open circles) and wild type (closed circles) 
C. saccharoperbutylacetonicum N1-4(HMT) grown on 40 g L -1 glucose in YETM media 
using shepherd lab fermenters. 0.1 M MES was supplemented as a pH buffering agent. (A) 
[butyric acid]; (B) [acetic acid]; (C) [acetone]; (D) [butanol]. 
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As the observed final concentrations of butanol and acetone were similar for ∆gapN and 
wild type strains, it was hypothesised that solvent toxicity was the limiting factor for these 
measurements. To test this hypothesis, a butanol toxicity test was carried out that measured 
growth rates in the presence of varying concentrations of solvents, as described in Section 
2.1.13. Deletion of the gapN did gene not have an effect on the cells ability to handle solvent 






































Figure 5.3 Butanol toxicity test of wild type (black bars) and ∆gapN (grey bars) strains of C. 
saccharoperbutylacetonicum N1-4(HMT). Cells were grown to an OD600 of 1 and were then 




In addition to growth, butanol toxicity, acid and solvent production, ATP concentrations were 
measured during the glucose batch fermentation. The ATP concentration in the ∆gapN 
strain compared to the wild type strain was higher for the majority of fermentation period 
(Figure 5.4). The greatest discrepancy in ATP concentration between the ∆gapN and wild 
type strains was observed at 15 h, where 11.2 µmol g -1 cell dry mass was recorded for the 







































Figure 5.4 ATP measurements for ∆gapN (open circles) and wild type (closed circles) C. 
saccharoperbutylacetonicum N1-4(HMT) grown in 40 g L -1 glucose in YETM media using shepherd lab 
fermenters. ATP concentrations were measured from cells that from a glucose batch fermentation in YETM 
supplemented with 0.1 M MES for pH control. ATP concentration of cells were measured in accordance to 









Due to the labile nature of NAD(P) derivatives, cells were grown in serum bottles and 
assayed at 4 h and 24 h to give an indication of the state of the cells in early exponential 
phase (acidogensis) as well as in late exponential/stationary phase (solventogenesis). 
Deletion of gapN did not appear to have an effect on the overall concentrations of both 
NADH and NADPH, however there is a marked reduction in the concentrations of NAD+ 
and NADP+ during both acidogensis and solventogenesis, indicating there is a more 
reducing environment present in the ∆gapN strain compared to the wild type (Figure 5.5).  
 
5.3 Characterisation of ∆gapN strain on a synthetic C5/C6 hydrolysate mixture  
 
To further investigate sugar utilisation in the ∆gapN strain, an additional batch fermentation 
was carried out this time using a synthetic C5 hydrolysate mixture consisting of 11 g L -1 
glucose, 14 g L -1 xylose, 4.65 g L -1 galactose, 1. 96 g L -1 arabinose and 18.4 g L -1 mannose 
in YETM. This medium is used by project partners to simulate industrial feedstocks made 
from waste lignocellulosic. Fermentation results show that when grown on the C5 sugar 
mix, the ∆gapN had an increased consumption rate for galactose, whereas all other sugars 
were consumed at the same or similar rates to the wild type strain (Figure 5.6). These data 
also demonstrate that both strains prefer C6 sugar utilisation compared to C5 sugars, which 
Figure 5.5 Concentration of nucleotide cofactors in both the wild type (black box) and the ∆gapN (grey 
box) during acidogensis (4h) and Solventogenesis (24 h). Cells were grown in YETM 40 g L -1 glucose in 
50 ml serum bottle reactions over the course of 24 h.  
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is consistent with previous studies on other solventogenic clostridial strains (Noguchi et al., 
2013)(Bogorad et al., 2013; Bruder et al., 2015; Fu et al., 2017).   
 
To complement the sugar utilisation experiments described above, it was of interest to 
investigate how the ∆gapN mutation impacted upon acidogenesis. In the glucose only batch 
fermentation, the concentration of acids associated with solvent production (i.e. acetic acid 
and butyric acid) were diminished throughout the fermentations in the ∆gapN strain (Figure 
5.2).  similar picture is observed during fermentation on the C5 hydrolysate mixture for the 
∆gapN strain (Figure 5.7A-B). The largest difference discrepancy between the wild type and 
∆gapN strains for butyric acid was seen at 12 h: butyric acid concentrations in the ∆gapN 
strain were 0.063 g L -1, which was x10 lower than the 0.60 g L -1 found in the wild type 
strain at the same timepoint (Figure 5.7B). Interestingly, in the C5 hydrolysate mixture there 
was an increase in the concentration of both formic acid and lactic acid in the ∆gapN not 
seen previously (Figure 5.7C-D). Unlike the solventogenic acids that are produced early on 
and assimilated into solvents, lactic and formic acid concentrations continue to increase 
throughout the duration of the fermentation. The largest discrepancy between the wild type 
and ∆gapN strains was observed at the end of the 48 h fermentation, with 0.37 ± 0.01 g L -
1formic acid produced in the ∆gapN strain and 0.295 ± 0.007 g L -1produced by the wild 
type. Similarly, 2.838 ± 0.005 g L -1and 2.1 ± 0.07  g L -1lactic acid was produced at 48 h in 
the ∆gapN strain and the wild type strain, respectively.  
 
In the synthetic C5 hydrolysate mixture, there was a pronounced increase in the 
concentration of acetone in the ∆gapN strain throughout compared to the wild type strain 
(Figure 5.7E). However, when grown on the C5 mixture, the butanol produced by the ∆gapN 



















Figure 5.6 Sugar profiles for ∆gapN (open circles) and wild type (closed circles) C. 
saccharoperbutylacetonicum N1-4(HMT) grown on C5 hydrolysate mixture using GBL 
fermenters. Cells were grown in a total sugar concentration of 50 g L -1. This medium contained a 
mixture of sugars that closely resembled a C5 sugar hydrolysate mixture containing glucose, 
xylose, maltose, mannose, galactose and arabinose. The pH was controlled via addition of 
ammonium acetate to maintain the pH above 5.2. Measured parameters were: (A) [glucose]; (B) 













5.4 Fed batch fermentation to assess glucose uptake and sugar utilisation in relation 
to solvent production 
 
In the experiments described in Section 5.2, the ∆gapN strain was grown in batch 
fermenters in YETM medium containing 40 g L -1 glucose. In summary, the ∆gapN strain 
exhibited an increase in glucose consumption throughout the batch fermentation and 
exhibited increased production of butanol and acetone to sub-toxic concentrations. In 
addition, a reduction in solventogenic acids acetic and butyric acid was observed in the 
Figure 5.7 Acid and solvent profiles for ∆gapN (open circles) and wild type (closed circles) C. 
saccharoperbutylacetonicum N1-4(HMT) grown on C5 hydrolysate mixture using GBL 
fermenters. Cells were grown in a total sugar concentration of 50 g L -1, this 50 g consisted of a mixture 
of sugars that closely resembled a C5 sugar hydrolysate mixture containing Glucose, Xylose, Maltose, 
Mannose, Galactose and Arabinose. pH was controlled via addition of ammonium acetate to maintain 
the pH above 5.2. Measured parameters were: (A) [acetic acid]; (B) [butyric acid]; (C) [formic acid]; (D) 
[lactic acid]; (E) [acetone]; and (F) [butanol]. 
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∆gapN strain compared to the wild type (Figure 5.3). To further test the glucose 
consumption rates observed in the first experiment and to investigate the behaviour of this 
newly constructed strain over a longer more metabolically intense period; a fed batch 
fermentation experiment was carried out. In this experiment, starting glucose 
concentrations of 50 g L -1  were at first  allowed to drop to just below 10 g L -1, and were 
then maintained at 10 g L -1, throughout. Throughout the fermentation, gas stripping using 
nitrogen at 1 volume of gas per fermenter volume per min was carried out to maintain 
solvent concentrations below toxic concentrations. The OD600 of the ∆gapN strain was 
maintained at similar levels to the wild type throughout (Figure 5.8A). The observed 
difference in pH did appear to coincide with the slightly elevated pH in the ∆gapN strain 
later in the fermentation (Figure 5.8B). Unlike the first YETM/glucose experiments, the 
∆gapN strain used less glucose throughout the fermentation and the rate of glucose 
consumption over the duration of the fermentation was also reduced in the ∆gapN strain 






















Figure 5.8 Growth parameters and glucose profiles for ∆gapN (open circles) and wild type (closed 
circles) C. saccharoperbutylacetonicum N1-4(HMT) grown in fed batch fermentations using GBL 
fermenters. Cells were grown initially in 50 g L -1 glucose YETM, following an initial batch of 16 h cells 
glucose concentrations were maintained as close to 10 g L -1 as possible. Measured parameters were: 
A) cell culture growth and density (OD600); B) pH; C) Concentration of glucose in medium; D) Glucose 
consumption rate g L -1 h -1.  
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Similarly, to the previous fermentations described in this chapter, there was a marked 
decrease in acetic acid and butyric acid throughout the fed batch fermentation in the ∆gapN 
strain (Figure 5.9A-B) as well as the observed increased concentrations in lactic and formic 
acid that were observed during the synthetic C5 hydrolysate fermentation (Figure 5.9C-D). 
Due to the gas stripping that was taking place during this fermentation, concentrations of 











Figure 5.9 Acid and solvent profiles for ∆gapN (open circles) and wild type (closed 
circles) C. saccharoperbutylacetonicum N1-4(HMT) grown in fed batch fermentations.  
Cells were grown initially in 50 g L -1 glucose YETM, following an initial batch of 16 h cells 
glucose concentrations were maintained as close to 10 g L -1 as possible. Measurements 




5.5 Discussion  
 
5.5.1 Observed increase in ATP production as a result of gapN deletion, leads to 
decreased acid production, earlier shift into solventogenesis as well as increased 
solvent production until pre-toxic concentrations 
 
The ∆gapN strain exhibits reduced concentrations of acetic and butyric acid with increased 
production of acetone and butanol to pre-toxic concentrations in both the glucose only batch 
fermentation (Figure 5.2) and the C5/C6 synthetic sugar mixture (Figure 5.7). As well as 
reduced concentrations of acids throughout, the assimilation of acetic and butyric acid 
occurs sooner in the ∆gapN strain than in the wild type strain, with butyric acid in ∆gapN 
strain during the glucose only fermentation peaking at 9 h and are then depleted by 18 h 
whereas in the wild type, concentrations of butyric acid do not peak until 15 h and are not 
completely depleted even towards the end of the fermentation (Figure 5.3A). A similar 
picture is seen in the C5/C6 synthetic mixture, here acid concentrations peak much earlier 
and are assimilated much earlier on in the ∆gapN strain compared to the wild type (Figure 
5.7).  
 
Despite the lower concentrations of acids, and their assimilation earlier on in fermentation, 
the ∆gapN strain is able to produce increased concentrations of solvents throughout until 
toxic concentrations are reached; this included initiation of solvent production earlier on in 
fermentation. This is observed in both the glucose only batch fermentation (Figure 5.2) and 
in the C5/C6 batch fermentation (Figure 5.7). The increase in solvent production is 
hypothesised to be a result of the increased ATP concentration (Figure 5.4) in tandem with 
the more reducing environment found in the ∆gapN strain compared with the wild type as a 
result of the ratio of NADH:NAD+ observed (Figure 5.5). Throughout the glucose only 
fermentation measured ATP is higher in the ∆gapN, however between 15-25 h there is an 
observable dip in the concentration of ATP in the ∆gapN strain (Figure 5.5), that correlates 
with the beginning of acid assimilation as well as the largest incline in solvent production 
during the fermentation (Figure 5.2). This suggest that deletion of ∆gapN increases ATP 
concentrations enough whereby the cell does not need to invest in acidogensis to generate 
enough of a ATP concentration to aid in the shift into solventogenesis. ATP and reducing 
cofactors such as NAD(P)+/H have been shown to be key in the shift into solventogenesis 
(Amador-Noguez et al., 2011; Girbal et al., 1995; Wang et al., 2012; Zhang et al., 2014) 
with key regulatory proteins such as Rex being closely linked with the reducing conditions 
with the cell (McLaughlin et al., 2010; Wietzke and Bahl, 2012; Zhang et al., 2014). 
Acidogensis occurs in the vegetative stage of growth and acts as a key stage for the 
accumulation of the ATP that will later be used for the production into solventogenesis 
(Grupe and Gottschalk, 1992). ATP in Clostridium spp. has also been documented as being 
responsible for ATPase proton translocation (Jones and Woods, 1986) within the cell that 
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aids in maintaining the proton gradient following the shift into solventogenesis to ensure 
ADP + Pi is recycled via a F1F0 ATPase to maintain ATP concentrations during 
solventogenesis when the overall production of ATP will be greatly reduced without acid 
production (Figure 1.2). V-type ATPases having been documented in Clostridium spp.  
(Boekema et al., 1998; Speelmans et al., 1994), however it is worth noting that C. 
saccharoperbutylacetonicum N1-4(HMT) like a handful of other Clostridium spp. contains 
an RnF complex. The RNF complex, like the ATPases found throughout allows C. 
saccharoperbutylacetonicum N1-4(HMT) generate an ion gradient, and in doing generate 
NADH via the oxidation of ferredoxin (Poehlein et al., 2017); something that others strains 
such as C. acetobutylicum lack. This combined with the data above aids in reinforcing the 
original hypothesis that deletion of gapN would subsequently result in higher ATP 
concentrations, reduced acid concentrations as well as increased solvent concentrations 
during fermentation, however, the earlier shift and assimilation of acids was unexpected in 
the original hypothesis.  
 
5.5.2 Increased production of lactic and formic acid in the ∆gapN strain 
 
In the synthetic C5 sugar mixture there was a marked increase in the production of formic 
acid (Figure 5.6C) and lactic acid (Figure 5.6D) in the ∆gapN strain. Similarly, the ∆gapN 
strain has an increase in the production of formic acid in the glucose fed batch fermentation 
(Figure 5.7C), however the difference in lactic acid was not as significant in the glucose fed 
batch (Figure 5.7D). In both experiments the concentrations of both lactic acid and formic 
acid have continued to rise even in the late stages of the fermentation. It has been 
documented that during the shift from acidogensis to solventogenesis in C. acetobutylicum 
there is a shift metabolically away from pyruvate into oxaloacetate (10 fold), as the cell 
moves away from amino acid production and to solvent production as carbon is redirected 
to acetyl coenzyme A for ABE production (Amador-Noguez et al., 2011). Due to the early 
shift into solventogenesis that is observed in the ∆gapN strain it is not unlikely to consider 
that the earlier shift results in an accumulation of pyruvate, that is then deals with by both a 
lactate dehydrogenase leading to lactate production and formic acid production via a 
pyruvate formate lyase. This suggests that as solvent production becomes saturated and 
butanol toxicity becomes a factor, the cell has to unload any excess pyruvate to enable 
solvent production to continue, hence the observed continual increases in formic and lactic 




5.5.2 The ∆gapN strain has same plight of CCR common amongst Clostridium  
 
Carbon catabolite repression (CCR) is common among a variety of solventogenic 
Clostridium. Regardless of strain or feedstock there is always a preferential uptake and 
metabolism of C6 sugars that utilise glycolysis over C5 sugars, in fact in the presence of a 
C5/C6 mixture often little to no C5 metabolism will occur even following depletion of C6 
sugars (Aristilde, 2017; Chang, 2010; Zhang et al., 2017). The problem of C5 metabolism 
is further exacerbated by the preferential metabolism that Clostridium have for individual 
C5 sugars over other C5 sugars (Aristilde et al., 2015). Many attempts have been made in 
a bid to elevate CCR in Clostridium, from alterations to fermentation procedures (Noguchi 
et al., 2013) and limiting glucose levels in lignocellulosic material (Bharathiraja et al., 2017). 
However, a large majority of the work has focused on genetically manipulating key 
regulators in the cell in a bid to elevate CCR. Deletion of glcG, a gene that encodes enzyme 
II of the D-glucose phosphoenolpyruvate-dependent phosphotransferase system (PTS) and 
join overexpression of key parts of the xylose pathway resulted in a yield increase of 5% 
over the wild type strain as well as an overall increase in titre by 24% (Xiao et al., 2011). 
Additional work has been carried out on Catabolite control protein A (CcPA). Identification 
and disruption of this protein has led to elimination of CCR in C. acetobutylicum (Ren et al., 
2012, 2010)(Ren et al., 2010). In this work, a synthetic C5/C6 mixture was used that had 
previously been used by our project partners to simulate feedstocks made from waste 
lignocellulosic material.  Overall, the deletion of gapN does not have an effect limiting CCR, 
the ∆gapN strain like the wild type has a preferential utilisation of the C6 sugars (mannose 
and glucose) in the synthetic C5/C6 mixture with incomplete consumption of C5 sugars in 
the presence of C6 sugars. Interestingly, there was a marked increase in the consumption 
of galactose in the ∆gapN compared to the wild type strain. Galactose, unlike other C6 
sugars such as glucose and mannose, is catabolized either via the Leloir pathway that 
generates G6P or the taga- tose-6P pathway that directly produces GAP and DHAP, and 
its catabolism has been shown to be suppressed in the presence of other preferential C6 






Chapter 6  
 
 




6 Final Discussion 
 
6.1 Establishment of growth conditions 
 
Along with many other Clostridium spp. C. saccharoperbutylacetonicum N1-4(HMT) is 
notoriously difficult to work with and culture due to the anaerobic nature as well as 
requirement a number of specialised equipment for their culture such as anaerobic 
chambers, serum bottles and fermentation systems. Significant time was spent during this 
project on optimising culture conditions and apparatus, which in turn enabled us to perform 
re-producing growth experiments with C. saccharoperbutylacetonicum N1-4(HMT) and 
other Clostridium spp. In addition to establishing fermentation technology, establishment of 
tools used for analysis of ABE products was carried out.  
 
The design and implementation of an effective fermentation system that enables batch, fed 
batch and continuous fermentation systems formed a large part of this work. Following 
extensive research (Table 3.1) an understanding of what is currently available on the 
market was established. Taking this knowledge forward allowed for the design and 
construction of a system that was flexible, affordable and importantly upgradable. The 
fermentation system developed herein may help to break the cost barrier of entry into 
fermentation on a smaller scale. Implementation of this sort of work could have a profound 
effect in the developing world, in particular regions such as Africa and Asia. These regions 
are areas of rapid economic growth, and will have an increasing need for research and 
development as economic diversification becomes more important. Having a flexible, 
affordable and upgradable piece of equipment could be invaluable in helping to establish 
interest in fermentative science in these regions. 
 
 
6.3 The impact of the deletion of gapN in C. saccharoperbutylacetonicum N1-4(HMT) 
 
The newly created ∆gapN C. saccharoperbutylacetonicum N1-4(HMT) was shown to have 
elevated concentrations of ATP (compared to the wild type strain) for a sustained period 
during batch fermentation (Figure 5.4). Between 15 – 24 h there is an observed drop in the 
measured ATP concentration of the ∆gapN strain over the wild type C. 
saccharoperbutylacetonicum N1-4(HMT). This observed decrease in ATP corresponds to 
the time points with the lowest concentrations of total acids production and the highest 
increase over time in solvent production in the ∆gapN strain (Figure 5.2).  
 
This data suggests that the resulting deletion of ∆gapN increases ATP concentration such 
that ∆gapN has a reduced acid production compared to the wild type strain to generate the 
required concentrations of ATP to allow for the shift into solventogenesis. In solventogenic 
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Clostridium acid production facilitates the generation of the majority of cellular ATP, this is 
a result of kinase activity of the enzymes involved in acetic and butyric acid production 
(Dürre and Hollergschwandner, 2004; Grupe and Gottschalk, 1992). The associated ATP 
generation in acidogenesis is important as it enables the cells to produce adequate 
concentrations of ATP for vegetative growth, as well as to establish an ion gradient via V-
type ATPases, alongside the RnF complex to generate NADH via the oxidation of ferredoxin 
(Poehlein et al., 2017). This ion gradient enables ADP + Pi recycling when the cells shifts 
into solventogensis via the use of F1F0 ATPases (Jones and Woods, 1986). By increasing 
the ATP producing capability as has been done here with the ∆gapN strain, it has been 
possible to reduce the reliance on acidogenesis in the cells and increase overall solvent 
production, due to the shortened acid generation phase, that is historically important for 
ATP generation for growth and solvent production.   
 
As well as an increase in ATP production, there is an increase in the ratio of NADH:NAD+ 
in the ∆gapN strain. ATP production, ∆pH generated by acid production and reducing 
conditions within the cell play a key role in the shift to solventogenesis (Liu et al., 2018; 
Wang et al., 2012; Wietzke and Bahl, 2012; Zhang et al., 2014). The increased reducing 
environment in ∆gapN is also thought to play a key role in conjunction to increased ATP 
resulting in an earlier shift into solventogenesis; which ultimately results in increased solvent 
production. A previous experiment in C. acetobutylicum in which a double over expression 
of 6-phosphofructokinase (pfkA) and pyruvate kinase (pykA) resulted in an increase in 
intracellular ATP and NADH, which also resulted in increased butanol and ethanol 
production, and additionally resulted in increased butanol tolerance in the double knockout 
(Ventura et al., 2013). It has been shown that in cultures with lower ATP production acid 
production prevails as a means of energy generation, whereas cultures with increased ATP 
produce more solvents (Meyer and Papoutsakis, 1989). Enhanced butanol production has 
also been by blocking NAD(P)H consumption in Clostridium beijerinckii NCIMB 8052, 
insertional inactivation of a NADH-quinone oxidoreductase (nuoG), resulted in increased 
NAD(P)H and ATP as well as butanol production (Liu et al., 2016). Overall it can be seen 
that increases in both ATP and NAD(P)H in solventogenic Clostridium aids in maximising 
the solvent producing potential of the bacteria.  
 
Previously it was shown that the shift into solvent production results in the redirection of 
pyruvate from amino acid production via oxaloacetate, decreasing this process 10-fold and 
redirecting pyruvate to coenzyme A for solvent production (Amador-Noguez et al., 2011). 
Deletion of gapN results in increased concentrations of formic and lactic acid during the 
C5/C6 fermentation (Figure 5.5), as well as during the glucose fed batch experiment (Figure 
5.7). This measured increase in both formic and lactic acid may result from the accumulation 
of pyruvate in the ∆gapN strain. Ultimately the solventogenic shift results in a redirection of 
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key metabolites away from vegetative cell growth by redirection off pyruvate towards solvent 
production. Accumulation of pyruvate may be due to further bottlenecks in the solvent 
production as well as an accumulation of pyruvate due to vegetative growth and sugar 
metabolism (Figure 6.1). As a way to cope with excess pyruvate generated by the earlier 
shift into solventogenesis, ∆gapN is producing excess concentrations of lactic acid via a 
lactate dehydrogenase and formic acid using pyruvate formate lyase.  
 
Finally, sugar metabolism of the ∆gapN was assessed to that of the wild type C. 
saccharoperbutylacetonicum N1-4(HMT). Initial glucose batch fermentations suggested an 
increased rate of glucose consumption in the ∆gapN strain, however subsequent fed batch 
experiments revealed that sugar consumption rates were comparable to the wild type strain, 
if not slightly less (Figure 5.8). In addition to glucose, the ∆gapN strain was subsequently 
grown on a C5/C6 mixture and revealed much like wild type, the new strain had a 
preferential catabolism of C6 sugars (glucose, mannose and galactose) over C5 sugars 
(xylose, arabinose) in the C5/C6 mixture. Interestingly, there was a preference towards 
galactose over glucose and mannose, contrary to what has been previously published in 
other Clostridium spp. (Aristilde, 2017) in which galactose catabolism is inhibited in the 
presence of glucose.  
 
Overall the deletion of gapN in C. saccharoperbutylacetonicum N1-4(HMT) results in an 
earlier shift into solventogenesis due to the increase in reducing conditions and increased 
ATP generated via elevated flux in the glyceraldehyde-3-phophate oxidation pathway. This 
ultimately leads to increased solvent production (pre-toxic concentrations), a decreased 
acidogenic phase and an earlier shift from vegetative cell growth to solvent production. The 
shortened acidogenesis that is a result of ∆gapN creation results in an accumulation of 
pyruvate that cannot be fully utilised due to the bottlenecks in solvent production, which in 
turn results in increased levels of formic and lactic acid. In addition, there is a marked 




























Figure 6.1 Overview of the deletion of gapN on C. saccharoperbutylacetonicum N1-4(HMT). 1) Deletion of gapN results in increased flux through GAPDH 
following deletion of gapN. 2). Increased flux through GADPH results in increased ATP concentrations that is leveraged to aid in the creation in of a ion gradient 
that can then be used to generate further ATP through ADP + Pi recycling. 3). Increased ATP and reducing environment within the cell results in a decrease in 
acid production. 4). Reduced acid production as a result of increased ATP and reducing environment results in earlier shift into solvent production. 5). The early 
shift into solvent production shifts flux throughout Acetyl-CoA from vegetative growth to solvent production. In doing this creates a bottleneck at pyruvate, this 
bottleneck is subsequently dealt with by the cell by increasing production of lactic acid and formic acid.  
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6.4 Future Studies 
Herein I have listed future studies that could be adapted from each chapter that would 
enable furtherment of the work presented.  
 
Chapter 3: 
• Establish a pH probe and control unit within an affordable price range that would 
allow for the “Shepherd lab” fermentation unit to overcome its largest inability. This 
can be achieved via the use of pH probes and custom software, perhaps written on 
an affordable computation device i.e. a Raspberry Pi  
• Further test “Shepherd lab” system in as many fermentation configurations as 
possible to reinforce the system as a viable affordable option.  
• Field test unit in developing country and further develop system if it does not fit 




• CLEAVEÔ has been used here for the creation of a single knockout in a region of 
the genome that does not form part of a cluster. To further test the ability of CLEAVE 
Ô,  layering change on top of the ∆gapN strain to create a multiple knockout or test 
the ability of the technology to introduce a gene that could aid in solvent or alterative 
compound production. 
• Sanger sequence SNP regions identified in Snippy to confirm that they are a result 
of sequencing or processing error and not a result of CLEAVEÔ 
• Further investigate ATP via NMR or other metabolomic techniques and identify any 
other accumulations of metabolites that are a result of the gapN knockout, and test 
ATP concentrations from a number of different growth conditions.  
 
Chapter 5: 
• Carry out proteomic studies of the ∆gapN strain during for a number of different 
time points and fermentation conditions to gain an understanding of protein 
concentrations at different stages, i.e. acidogensis and solventogenesis to gain 
better insight into the effects that the earlier observed shift into solventogenesis 
has on a cell wide basis.  
• Try and engineer or investigate ways of increasing the ∆gapN tolerance to 
butanol toxicity.  
• Optimise fermentation conditions that can take advantage of the earlier shift into 
solventogenesis that leads to peak solvent production sooner than in the wild 
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Appendix A-2 – List of components used in designed fermentation system.  
This list is extensive for the components of the culture vessel itself, alongside the 
probes used in the measurements of pH and Redox. Peristaltic pumps used were 
already part of the lab equipment as well as the magnetic stirring plate.  
 
 
Component Brand Link to purchase 
1 L Culture 
Vessel 
FV1L QUICKFIT 1LT CULTURE 








MAF4/41 QUICKFIT LID 100MM 
FLAT FLANGE 3 X SOCKETS 








PS100 QUICKFIT 100MM FLAT 




Lid to vessel 
clips  
JC100F QUICKFIT JOINT CLIPS 









0.2 µM gas 
filters 

































































Gas out - Short tube 
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Continuous   
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Appendix E – Qualimap results – Separate PDF 
 






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Appendix G – IGV Manually investigated SNP’s in both WT and ∆gapN strain 
 




















































Appendix H – Gene presence and absence Via Roary analysis 
 
 

























Appendix I. Initial colony PCR screens of ∆gapN colonies post transformation with killing vector. Lanes 
highlighted with red correspond to the CRPC reaction of the ∆gapN deletion, to the right of each of these, 
not highlighted are the corresponding 16S colony PCR reactions that show the successful CPCR for these 
reactions.  
